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Abstract
Background: Contemporary biological observations have revealed a large variety of mechanisms acting during the
expansion of a tumor. However, there are still many qualitative and quantitative aspects of the phenomenon that
remain largely unknown. In this context, mathematical and computational modeling appears as an invaluable tool
providing the means for conducting in silico experiments, which are cheaper and less tedious than real laboratory
experiments.
Results: This paper aims at developing an extensible and computationally efficient framework for in silico modeling
of tumor growth in a 3-dimensional, inhomogeneous and time-varying chemical environment. The resulting model
consists of a set of mathematically derived and algorithmically defined operators, each one addressing the effects
of a particular biological mechanism on the state of the system. These operators may be extended or re-adjusted,
in case a different set of starting assumptions or a different simulation scenario needs to be considered.
Conclusion: In silico modeling provides an alternative means for testing hypotheses and simulating scenarios for
which exact biological knowledge remains elusive. However, finer tuning of pertinent methods presupposes
qualitative and quantitative enrichment of available biological evidence. Validation in a strict sense would further
require comprehensive, case-specific simulations and detailed comparisons with biomedical observations.
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Background
Introduction
Cancer is one of the main causes of mortality in the
world. Statistics estimate that about one fifth of the
population will suffer from cancer at some point in their
lives [1]. Cancer is a category of diseases, which share
several common features including sustained and uncon-
trolled cell proliferation, resistance to cell death, induc-
tion of angiogenesis, and activation of invasion and
metastasis mechanisms [2].
The exact mechanisms that initiate cancer develop-
ment remain largely unknown. However, it is widely ac-
cepted that cancer originates from cells which, due to
various gene mutations, escape the body’s natural
mechanisms of controlling the balance between cell
proliferation and cell death [3]. These cells create a
clump which grows faster than host cells. However, this
small tumor grows with a decreasing rate; as the tumor
grows, disorganization of the host vasculature and lim-
ited diffusion of nutrients to the center of the tumor
lead to the formation of an internal necrotic core [4, 5].
Cells in the outer rim of the tumor proliferate, while
cells in the interior die. For the tumor to grow large and
become malignant, it needs to establish its own blood
supply network, a process called angiogenesis. Angiogen-
esis results in a highly disorganized, tortuous and dilated
vasculature, [4, 6–8] which however, provides the nutri-
ents needed for further tumor growth. Evidently, during
both the avascular and vascular phase of tumor develop-
ment, the provision of nutrients to tumor cells through
the blood supply network is highly inhomogeneous and
time varying [4, 9–11]. In fact, many studies have shown
that tumors contain hypoxic and hypoglycemic regions,
particularly near the center, which affect local cell
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proliferation and death rates [4, 12, 13] and references
therein.
Contemporary medical and biological literature on the
subject shows that the vast majority of observations and
results are conclusive only up to a point. In fact, there
are still many qualitative and quantitative aspects of
tumor progression that remain largely unknown. In this
context, in silico modeling appears to be an invaluable
tool for simulating scenarios and testing hypotheses per-
taining to the aforementioned biological phenomena. To
this end, this work describes an extensible and computa-
tionally efficient framework for in silico modeling of
tumor growth in a 3-dimensional, inhomogeneous and
time-varying chemical environment.
Related literature
During the last few decades, mathematical and computa-
tional modeling of tumor growth has received a lot of at-
tention from the scientific community. However, as
noted in [14], there are no established first principle the-
ories in cell-tissue modeling, and this seems to be the
case even for today. Furthermore, there is still no gener-
ally agreed consensus on which modeling approach is
the most suitable for modeling tumor growth. Scientists
with different backgrounds have employed a variety of
methods to attack the problem, in an effort to provide
tools for conducting in silico experiments, which are
significantly cheaper and less tedious than real labora-
tory experiments. Inspection of the literature shows that
papers on the particular subject fall into two categories.
Papers in the first category aim at an at least partial val-
idation of a model against actual measurements. Such
works include [15–18]. Papers in the second category
aim at proposing new modeling methods or advancing
already existing ones. Our work belongs in the second
category.
In this section, we will review the main methods which
have been most commonly employed in the pertinent
literature.
Population models were probably among the first, sim-
plest and yet effective of these approaches and utilize
both deterministic and stochastic mathematics [19].
These models neglect tissue spatial structure and focus
on the dynamics of the involved cell populations. They
can address a variety of phenomena such as tumor
clonal heterogeneity [20–22], tumor-host cell interac-
tions [23–25] and response to therapy [26–29].
Despite the usefulness of population models, the
spatial structure of tumors and the tissues they grow in
appears to play an important role in tumor growth. To
address this, several models have been proposed, with
discrete entity, cell-based models forming a concrete
class of such approaches. In these models, each tumor
cell is treated as a discrete agent reacting to changes in
its environment according to its own internal decision
mechanism. Partial differential equations are most usually
employed to model the background chemical environment.
Most common approaches include lattice-based [30–42],
lattice-free [14, 43–45] and Potts models [46–50]. Discrete
agent models can address pertinent cellular, biochemical
and biomechanical phenomena in considerable detail.
However, they are computationally expensive and thus can
simulate tumor sizes ranging in the order of at most 106
cells, often considered in 2 dimensions.
Another popular approach is modeling the concentrations
of both cells and chemical substances as continuous,
spatially distributed quantities. Reaction-advection-diffusion
equations are most commonly employed to model multicel-
lular tumor spheroids [51–54]. Mainly for (but not limited
to) the case of gliomas, the reaction diffusion equation is
invoked to model the infiltration of tumor cells in the
surrounding healthy tissue [55–61].
In [62, 63] the authors simulated the temporal evolu-
tion of non-necrotic, 2- and 3- dimensional tumors
modeled as a continuum using a moving boundary.
Using level set methods, this approach was extended in
[64–68]. These papers demonstrate 2-dimensional simu-
lations which additionally considered angiogenesis, ne-
crosis and features of the tumor microenvironment.
A different approach, employing diffuse interface, multi-
phase mixture models was taken in [69, 70]. In these
works, tissue is modeled as a multiphase mixture of solid
components (e.g. dead tumor cells, viable tumor cells, host
tissue) and water. Their temporal evolution is derived by
mass equations and thermodynamic constitutive laws.
Further work on this approach includes [71–73] where
the authors consider additional phenomena like angiogen-
esis and biomechanical effects.
Miscellaneous approaches include the spatially aver-
aged cellular automata developed in [74–76] where space
is discretized in voxels, each one containing a number of
cells. The resulting cubic grid is treated as a cellular au-
tomaton, with specified rules governing the transition of
cells through the cell cycle phases within each voxel, the
expansion of the tumor and the effects of various treat-
ment modalities. In [77, 78] a hybrid approach was taken;
cell distributions were modeled as continuous quantities
except for the proliferating regions at the tumor boundary,
where cells were treated as discrete entities. For a recent
collection of articles on multiscale cancer modelling we
refer to [79].
Results
This paper develops a method for modeling 3-dimen-
sional tumor growth with an emphasis on macroscopic
variables. More specifically, we focus on variables quan-
tifying the spatial distribution of cells and molecules, the
provision of nutrients by the vascular system, tumor cell
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proliferation and invasion, the effects of tumor-induced
vascular remodeling and how they affect each other as
the tumor grows. Inspired by the aforementioned litera-
ture, our work aims at providing an additional useful
tool for in silico experimentation with the following
properties:
a) The resulting model is modular; that is, it consists
of several discrete mathematical/algorithmic
modules, each one addressing a particular biological
phenomenon. This allows keeping track of the
assumptions made for each module. Furthermore, it
facilitates model readjustment in case a new set of
hypotheses needs to be considered. As we will show
in the following sections, this can be done by
extending or even completely redesigning the
modules pertaining to the new hypotheses.
b) Although some of the models mentioned in the
literature can address phenomena even at the single
cell level, they are in general computationally
intensive. For some of them, simulation times in the
order of 10–24 h have been reported [39, 69]. This
imposes restrictions on the shape and size of the
simulated tissue; therefore, many models consider
only 2-dimensional tumors or spheroids with
maximum size in the order of a few mm3. However,
realistic tumors can grow up to several cm3 in
volume. Besides that, as demonstrated in [40],
results obtained from simulated small tissue areas
generally cannot be extrapolated to larger domains.
This implies that a balance between consideration
of microscopic details and the ability of simulating
larger regions of tissue must be kept. The methods
developed in this paper aim at a resulting model
that can simulate large (in the order of cm3) areas
of tissue in 3 dimensions, with a spatial resolution
in the order of 1–2 mm3, i.e. the voxel size of
contemporary imaging techniques.
c) Tumor growth consists in a complex interaction of
phenomena evolving in different time scales. From
the macroscopic point of view we adopt, the
shortest time scale concerns the diffusion of
molecules (seconds) and the largest one the overall
tumor expansion (months). It is definitely a
challenge to choose an appropriate simulation time
step, i.e. one that addresses all the involved
mechanisms in a sufficient amount of temporal
detail, while keeping the simulation computationally
tractable. Therefore, some models focus solely on
cell proliferation and neglect the local availability
and diffusion of nutrients [50, 54–61, 74–76].
Another common approach is to choose a time step
in the order of minutes or hours, and solve the
resulting (quasi-) steady state equations for the
diffusion of nutrients [30–32, 41, 45, 52, 62–64, 66,
68, 70, 71, 73]. The methodology proposed in this
work aims at time steps in the order of the shortest
time scale, i.e. in the order of seconds.
d) We also aim for computational efficiency, meant in
a twofold sense.
 First, in conjunction with (b) and (c) above. The
simulations we present here consider tissue areas in
the order of 4.2 × 4.2 × 4.2 cm3, with a spatial
resolution of 2 mm3 and a time step of 10 s for a
time period of 3 months. The average simulation
time on a standard desktop computer is about 10–
12 min. The model is implemented in MATLAB;
implementation in a precompiled language like C is
expected to significantly decrease this time.
 Second, for scalability reasons, the resulting model
should be able to exploit multicore computation.
We will show in part VII of the methods section
that the collection of all model variables at each
time instant (i.e. the state vector) essentially evolves
in a dynamical systems fashion. Given the current
state, the next state can be calculated by a sequential
application of algorithmically defined operators.
Each one of these operators is perfectly eligible for
parallelization, thereby enabling implementations
considering larger tissue areas with finer spatial and
temporal resolutions.
Discussion
In this paper we present a novel methodology to ap-
proach the still open problem of modeling tumor
growth. The presented modeling framework casts the
problem in the realm of spatially distributed, stochastic
dynamical systems by placing all pertinent spatial vari-
ables in a set of vectors, which collectively define the
state vector of the overall system. At each time instant, a
series of mathematically derived and algorithmically
defined operators, each one corresponding to a particu-
lar biological mechanism, are applied to the state vector.
Within the proposed framework, each one of these oper-
ators may be redesigned to consider different sets of
starting assumptions, resulting generally in computation-
ally efficient implementations. This facilitates the design
of a large variety of hypothesis testing scenarios and cor-
responding in silico experiments, a process which, with
the current limited qualitative and quantitative know-
ledge on the subject, seems inevitable. Several use cases
are presented. Since we present simulations for a specific
model, we do not attempt more detailed comparisons
with biological data. Undoubtedly, there is still a lot of
ground to be covered. Enrichment of both biological
Antonopoulos et al. BMC Bioinformatics          (2019) 20:442 Page 3 of 36
measurements and pertinent qualitative observations is
necessary for further improvement of such methods. Fu-
ture work should include much more case-specific and
detailed comparisons between simulation results and
available biological evidence.
Conclusions
We have developed an extensible and computationally
efficient framework for modeling tumor growth in a
three-dimensional inhomogeneous and time-varying
chemical environment, which constitutes an in silico al-
ternative for testing different hypotheses and simulation
scenarios. The model has been applied in the context of
several use cases in order to visualize various aspects of
tumour expansion and a multivariate analysis of the ef-
fects of model parameters on the number of live cancer
cells of a growing tumor has been performed. Since
many aspects of the pertinent biological mechanisms
remain still largely unknown, finer tuning and validation
of the simulation system in a strict sense presupposes
qualitative and quantitative enrichment of the available
biological evidence.
Methods
The rest of the paper is organized as follows. In section I
we present the main ideas used to model the diffusion of
particles. In section II, we discuss boundary conditions.
Sections III and IV specialize the ideas of the previous
sections in the cases of chemical and cellular diffusion.
Section V discusses tumor cell metabolism and con-
sumption of nutrients, and how they affect proliferation
and necrosis. In section VI we model the macroscopic
effects of tumor-induced vascular remodeling. Section
VII presents the complete model architecture. In section
VIII we present some use cases, including a multivariate
study on the effects of various model parameters on the
number of viable tumor cells after a period of free
growth.
I. Modeling the diffusion of particles
The diffusion of particles is a natural phenomenon
present in a vast variety of models regarding tumor
growth. To model such phenomena, the diffusion partial
differential equation is most commonly invoked:
∂c
∂t
¼ ∇  ðD∇cÞ ð1Þ
where c(x, t) is the concentration of the species under
consideration (cells or molecules) at time t and location
x, and D the diffusion tensor of the species in the sur-
rounding material. This equation has been widely used
to model cell diffusion, particularly in the case of glio-
blastoma, as well as diffusion of molecules in tissue. In
the case of isotropic diffusion D is a constant scalar, and
equation (1) reduces to
∂c
∂t
¼ DΔxc ð2Þ
where Δx is the Laplace operator in ℝ
3. In [80] we elabo-
rated on the observation that (2) is the Fokker-Planck
equation corresponding to the stochastic differential
equation
dxt ¼
ﬃﬃﬃﬃﬃﬃ
2D
p
 dBt ð3Þ
where Bt denotes the standard Brownian motion in ℝ
3.
Given the initial position xo of a particle, the distribution
of the random variable xt (i.e. the solution of (3) at time
t) provides c (x, t), i.e. the probability distribution over
all possible locations of this particle at time t. The initial
position of the particle may also be given in terms of a
probability distribution c (x, 0). In this case, the probabil-
ity distribution c (x, t) can be found by either of two
equivalent ways: By solving (2) as a partial differential
equation with initial value c (x, 0) to find the timely evo-
lution of this distribution, or equivalently, by solving the
stochastic differential equation (3) with initial distribu-
tion c(x, 0) to find the probability distribution of the ran-
dom variable xt.
To consider the collective movement of a population
of particles, that is, molecules or cells located within a
specified anatomic region, this notion of distribution can
be utilized as follows: integration of c(x, t) over a region
A of ℝ3 provides the fraction of the total particle popula-
tion that is located in A at time t.
To model anisotropic diffusion, i.e. the preferential
stochastic movement of particles along locally specific
unit directions, the notion of the local diffusion ellipsoid
(i.e. the diffusion tensor) is needed [59]. This notion
corresponds to defining an ellipsoid in each point of the
3-dimensional space under consideration. Mathematic-
ally, this is made explicit by defining, in each point, a
3 × 3 positive definite symmetric matrix:
D ¼
Dxx Dxy Dxz
Dxy Dyy Dyz
Dxz Dyz Dzz
2
4
3
5
This matrix can be decomposed in the following form:
D ¼ u1 u2 u3½ 
λ1 0 0
0 λ2 0
0 0 λ3
2
4
3
5 u1 u2 u3½ T
where λ1, λ2, λ3 are the eigenvalues of D and u1,u2, u3
are the corresponding orthonormal eigenvectors. We
note that D is positive definite, hence λ1, λ2 and λ3 are
positive numbers. The eigenvalues and eigenvectors of D
define an ellipsoid whose principal axes lie on the
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directions of u1, u2 and u3. The principal axes have
lengths 2
ﬃﬃﬃﬃﬃ
λ1
p
, 2
ﬃﬃﬃﬃﬃ
λ2
p
and 2
ﬃﬃﬃﬃﬃ
λ3
p
, respectively. The diffu-
sion ellipsoid is depicted in Fig. 1.
The anisotropic diffusion of particles as dictated by
the (local) diffusion ellipsoid can be modelled as follows;
let p(x, xo, dt) denote the probability of a particle starting
at xo to be at x after time dt. Then
p x; xo; dtð Þ ¼ 1
2πð Þ3

2 det ULaUT
 1
2
exp −
1
2
x−xoð ÞTUL−1a UT x−xoð Þ
 
ð4Þ
Where
La ¼
λ1α 0 0
0 λ2α 0
0 0 λ3α
2
4
3
5 L−1a ¼
1
λ1α
0 0
0
1
λ2α
0
0 0
1
λ3α
2
666664
3
777775 U ¼ u1 u2 u3½ 
Note that the right-hand side of (4) is essentially an
anisotropic Gaussian in ℝ3. The parameter α is a positive
scalar, specific to the particles under consideration
which in our case, will be tumor cells. This parameter
rescales the eigenvalues, thereby rescaling conformally
the axes of the diffusion ellipsoid. This reflects the fact
that different kinds of particles may tend to move along
the axes of same ellipsoid, but may do so with different
velocities. Of note, since we are considering a local
diffusion ellipsoid, in the most general case both eigen-
values and eigenvectors are functions of the position x.
After some mathematical elaborations detailed in [80],
equation (4) leads us to model anisotropic diffusion by
xtþdt−xt ¼ U
ﬃﬃﬃﬃﬃﬃﬃ
αλ1
p
0 0
0
ﬃﬃﬃﬃﬃﬃﬃ
αλ2
p
0
0 0
ﬃﬃﬃﬃﬃﬃﬃ
αλ3
p
2
64
3
75b
where b is a 3-dimensional, normally distributed random
vector with zero mean and covariance matrix the iden-
tity matrix times dt:
b  1
2πð Þ3

2 dtð Þ3

2
exp −
bTb
2dt
 
¼ 1
2πð Þ3

2 dtð Þ3

2
exp −
bk k2
2dt
 !
or equivalently, by the stochastic differential equation
dxt ¼
ﬃﬃﬃ
a
p  UðxÞL1

2ðxÞdBt ð5Þ
For a given initial distribution c(x, 0) the solution of (5)
provides the probability distribution of the random variable
xt, which can be interpreted exactly as described for the iso-
tropic case. In the case of brain tumors, measurements con-
cerning the diffusion tensor are obtained through the
Diffusion Tensor Imaging (DTI) technique [56, 59].
In our approach, equations (3) and (5) will constitute
the theoretical basis for modelling chemical and cellular
diffusion.
Let us now assume that the diffusion of the particles
(molecules or cells) under consideration takes place in a
cubic lattice consisting of N ×N ×N geometrical cells
(voxels). Each voxel is a cube of dimensions Δs × Δs × Δs.
We fix a temporal discretization step equal to Δτ. Voxels
in that cubic lattice can be classified into 4 categories,
depending on the number of their neighboring voxels
within the lattice. Voxels in the interior of the lattice
have 26 neighbors. Voxels at the outer faces of the lat-
tice have 17 neighbors. Voxels at the outer edges of the
lattice have 11 neighbors and voxels at the outer vertices
of the lattice have 7 neighbors. Furthermore, for each
particular voxel, its neighboring voxels fall into 3 cat-
egories: the ones that share a common face, the ones
that share a common edge and the ones that share a
common vertex with the particular voxel.
For the remaining part of this section, let us adopt the
assumption that, at each discrete time point, the distri-
bution of the particles under consideration within each
voxel is uniform. This is somewhat oversimplifying, and
we will further elaborate on this assumption in the fol-
lowing sections, where we specifically consider chemical
or cellular diffusion. For the moment, this assumption
will render the presentation of the main ideas more
straightforward.
Under the uniformity assumption, at any discrete time
point t and for any pair of voxels A and B (not necessar-
ily different) we can calculate the probability for a par-
ticle to lie within B at time t + Δτ, given that its position
at time t is a uniformly distributed (u.d.) random vari-
able supported in A. Numerical integration of equations
(3) and (5) for a uniform initial distribution provides the
means for a Monte Carlo calculation of this probability,
which we will denote by Pr(A→ B).
Fig. 1 The diffusion ellipsoid
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Let A denote a voxel not lying on the boundary of the
lattice nor being adjacent to it, and Bi, i = 1, …, 26 its
neighbors. A key step to our discretization process is to
choose the voxels’ edge length Δs and the time step Δτ
such that, from one time instant to the next one, the
particles lying in each voxel diffuse at most into its
neighbors. Mathematically, this means that Δs and Δτ
should be chosen such that
Pr A→Að Þ þ
X26
i¼1 Pr A→Bið Þ ¼ 1 ð6Þ
If (6) holds then, for a spatially constant, isotropic dif-
fusion like the one implied in (3), for each voxel A not
lying on the boundary of the lattice nor being adjacent
to it, these probabilities consist of essentially 4 numbers:
one for the particles that are in A and will remain in A
(i.e. Pr(A→ A)) and three more, one for each of the
common face, common edge and common vertice
neighbors of A. Furthermore, for any two voxels A and
B it holds that Pr(A→ B) = Pr (B→A). For a spatially
varying, anisotropic diffusion like the one implied in (5),
these symmetries do not hold; the respective probabil-
ities should be precalculated independently for any par-
ticular voxel.
Thus, under the uniformity assumption, for any voxel
A not lying on the boundary of the lattice nor being ad-
jacent to it, knowing the particle population of the voxel
Qt(A) and its neighbors Qt(Bi), i = 1, …, 26 at a time in-
stant t, allows us to calculate the population within A at
the next time instant t + Δτ by
QtþΔτ Að Þ ¼ Pr A→Að ÞQt Að Þ
þ
X26
i¼1 Pr Bi→Að ÞQt Bið Þ ð7Þ
Apparently, this equation does not hold as such when
the voxel under consideration lies on the boundary of
the lattice. We will deal with these voxels (and their
neighbors) in detail in the next section, where we discuss
boundary conditions.
In what follows, it will come in handy to represent
particle quantities within the voxels in vector form. Let
us make this representation explicit by the following
construction. Let the coordinates of each voxel in the
lattice be given by a triad of integers, (i, j, k) where i,
j, k = 1, …, N. We define a mapping L :ℕ3→ℕ as fol-
lows: L(i, j, k) = i + (j − 1)N + (k − 1)N2. This mapping is
a bijection from the set of triads (i, j, k), i, j, k = 1, …,
N to the integers from 1 to N3. Let Q(i, j, k) denote
the quantity of particles in the respective voxel. We
define the vector q of N3 elements by q(L(i, j, k)) =
Q(i, j, k). By this construction, the elements of the 3d
matrix Q are explicitly mapped to the elements of the
one-dimensional vector q.
II. Dirichlet and Neumann boundary conditions
Knowing the particle population within each voxel of
the lattice at a time instant, equation (7) allows us
to calculate the population within each voxel at the
next time instant for all the voxels, except the ones
on the boundary of the lattice and their neighbors.
Each of the boundary voxels has less than 26 neigh-
bors. In fact, each of these voxels would have 26
neighbors in an infinite lattice, but not all of them
are included in a bounded, N ×N × N lattice. Unless
we specify boundary conditions, the calculation in
(7) cannot be carried out neither for those voxels
and consequently, nor their neighbors. There are
two types of boundary conditions that can be im-
posed in a classical diffusion problem, those of the
Dirichlet type and those of the Neumann type. In
this work, we consider two specific types of such
boundary conditions, namely, the time-independent
Dirichlet and the homogeneous Neumann boundary
conditions.
Time-independent Dirichlet boundary conditions
express the requirement that on the boundary of the
region under consideration, the quantity of interest
does not change with time. In the framework pre-
sented here, this is expressed mathematically by the
following: If a voxel A lies on the boundary of the
lattice, to calculate its population at the next time in-
stant, instead of equation (7) simply apply Qt + Δτ(A) =
Qt(A). Additionally, if a voxel is adjacent to the
boundary, simply apply (7) by using the respective
probabilities as they are calculated from the numerical
integration of (3) or (5).
We note that in the case of tumor growth, some au-
thors have also considered time-dependent, periodic
Dirichlet boundary conditions [40]. This is also feasible
in the proposed framework, and can be implemented as
follows. For any boundary voxel A, at any time instant t,
apply Qt(A) = gt, where gt is the desired periodic
function.
Homogeneous Neumann boundary conditions ex-
press the requirement that the flux of the quantity of
interest across the boundary of the region under con-
sideration should be zero, i.e. the boundary is non-
permeable. In terms of calculus this is expressed by
the requirement, at any time instant and at any point
of the boundary, the projection of the gradient of the
quantity on the outward normal of the boundary at
that point to be zero. In the stochastics literature, a
non-permeable boundary within which a random mo-
tion takes place is often referred to as a reflecting
boundary [81]. In the framework presented here, this
is expressed mathematically as follows.
As previously mentioned, any voxel A lying on the
boundary has 17, 11 or 7 neighbor voxels which we
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denote by Bi, where i is an integer from 1 up to 17, 11
or 7, depending on the position of the voxel. For each
such voxel A, and its neighbors Bi we calculate the prob-
abilities Pr(A→ Bi) as described in the previous section,
but only for the voxels that are contained in the lattice.
Specifically, if A lies on the boundary, we calculate the
probabilities Pr(A→A), Pr(A→ Bi) where i is an integer
from 1 up to 17, 11 or 7. We then normalize these prob-
abilities to sum to one. By this calculation we acquire
the probabilities we need, in order to apply equation (7)
for any voxel in the lattice. Using these normalized prob-
abilities when applying equation (7) for either boundary
voxels, or their neighbors, ensures that every particle
lying in a voxel on the boundary, will remain within the
lattice, that is, within the region of interest, thereby cap-
turing the notion of a reflecting boundary.
In our case, the region of interest is a cube. It is
apparent that these methods of imposing Dirichlet or
Neumann boundary conditions apply to more com-
plex shapes, as long as space is properly discretized
[82]. The case of brain tumors, where the skull natur-
ally imposes a reflecting boundary to the diffusion of
tumor cells is an example where this approach may
be useful.
III. Diffusion of glucose and oxygen
In this section we will use the ideas presented previ-
ously to develop a model for the diffusion of chemical
molecules (glucose or oxygen) in the region of inter-
est, that is, the cubic lattice of dimensions N ×N ×N.
For the moment, we will assume that the diffusion is
isotropic and that the distribution of molecules within
each voxel is uniform. Let qt denote the N
3 × 1 vector
whose entries are the quantities of the molecule
under consideration within each voxel at time t. Αs-
suming time-independent Dirichlet boundary condi-
tions, equation (7) implies that if we know qt, we can
calculate qt + Δτ by performing a linear calculation.
This means that there is a N3 ×N3 square matrix T
such that qt + Δτ = Tqt, .
We remind the reader that due to the symmetries
holding for isotropic diffusion, for each voxel A not on
the boundary, we can apply equation (7) by using only
four numbers. We denote these numbers by Pr(A→ A),
Pr(F→A) (for common face neighbors), Pr(E→A) (for
common edge neighbors), and Pr(V→A) (for common
vertex neighbors). These numbers can be precalculated
by numerically integrating (3) for a uniform initial distri-
bution, where in each case, D is taken to be the diffusion
coefficient of the respective molecule. We subsequently
use these values and the mapping L defined in section I
to construct the matrix T according to the following
algorithm:
Note that, in view of the mapping L, each row i of T cor-
responds to a specific voxel A, i.e. to a specific position i
of the vector qt +Δτ. The nonzero entries of the particular
row correspond to the probabilities Pr(A→A) and
Pr(Bi→A), where Bi are the neighbors of A, as indicated
by (7). Furthermore, each column j of T corresponds to a
specific voxel B, i.e. to a specific position j of the vector qt.
The nonzero entries of the particular column correspond
to the probabilities Pr(B→ B) and Pr(B→Ai), where Ai
are the neighbors of B. Probabilities of the type Pr(A→A)
lie in the main diagonal of T.
In our model, we will use two such matrices, one for glu-
cose and one for oxygen, denoted by Tgl, To respectively. Each
of the respective N3 × 1 vectors will be denoted by glt, ot.
The matrix constructed by Algorithm 1 has an inter-
esting property. For sufficiently large N and due to the
assumption implied in equation (6), it is a sparse matrix:
in each row, at most 27 elements are nonzero. This pro-
vides a significant relief of the computational burden of
the entire model.
Note that all arguments in this section, resulting in the
simple model qt +Δτ =Tqt for molecular diffusion, rely on
the uniformity assumption as it was stated in section I.
We mentioned that this assumption is somewhat
oversimplifying. Indeed, in vivo measurements in
tumor areas show that chemical gradients can be
spatially non-uniform and time varying. Reportedly,
oxygen profiles can vary locally up to 50% within an
hourly time frame [83]. The highly irregular tumor
vasculature may further complicate things and pertin-
ent biological mechanisms remain largely unknown
[6, 7]. Inherent stochasticity is also expected to play a
role. Consequently, detailed quantification of the inflicted
macroscopic effects such as time evolution of chemical
fields seems currently infeasible. Therefore, we broaden
our perspective as follows.
First, we note that our calculations showed that for
both oxygen and glucose, it holds that Pr(A→ A)>
Pr(F→A)> Pr(E→ A)> Pr(V→A) and that each of these
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numbers is one order of magnitude greater than the next
one. Therefore, we will use the precalculated numbers
Pr(A→A), Pr(F→ A), Pr(E→A), and Pr(V→ A) only as
estimates for the (relative) orders of magnitude of these
probabilities. To take the largely stochastic, collective ef-
fect of the aforementioned complex mechanisms and
uncertainties into consideration, we will choose a time
step Δτ in the order of seconds (i.e. the time scale of
chemical diffusion) and introduce a certain degree of
randomness to the matrices Tgl and To. Specifically,
every some time steps, each column of these matrices
corresponding to a voxel in the interior or in the vicinity
of the tumor will be randomly perturbed, such that its
nonzero entries retain their relative orders of magnitude
and their sum remains one. We provide the respective
implementation details in the appendix.
Introducing stochasticity implies that for each simula-
tion scenario, several simulations will be required. None-
theless, the results of these multiple simulations will
enable a more comprehensive consideration of possible
outcomes.
IV. Diffusion of tumor cells
To model the diffusion of cancer cells, we make the fol-
lowing assumptions:
i. There are four types of cells within each voxel; live
normal (host) cells, necrotic normal cells, live
tumor cells and necrotic tumor cells.
ii. For any voxel, there is an average cell population
capacity (tumor +normal) which we denote by M
and a maximum cell population capacity which we
denote by Mmax.
iii. As the tumor grows, live normal cells become
either dislocated by invading tumor cells or
necrotic.
iv. When the sum of living cancer, necrotic cancer and
necrotic host cells in a voxel exceeds Mmax, living
cancer cells in excess of Mmax invade neighboring
voxels according to equation (5).
v. Both tumor and normal necrotic cells remain in the
voxel they became necrotic, that is, they do not
“invade” neighboring voxels.
Our model will be based on equations (5) and (7).
Since we assume that in each voxel, only tumor cells
in excess of Mmax diffuse to neighboring voxels, the
probability Pr(A→ A) is not needed. For each voxel A
and its neighbors Bi we calculate the probabilities
Pr(A→ Bi) and normalize them to sum to 1. We then
place these probabilities in the respective rows and
columns of a matrix Tc, similar to the matrices Tgl
and To of the previous section. Of note, the main di-
agonal of the matrix Tc consists of zeros, and not of
probabilities Pr(A→ A), as is the case with Tgl and
To. Apparently, the matrix Tc is also sparse, lightening
thereby the computational burden. Furthermore, by
construction, the matrix Tc implies homogeneous
Neumann boundary conditions for living tumor cells.
The tumor cell diffusion algorithm has a quite simple
implementation. Let lt, nct, nnt denote the N
3 × 1 vectors
whose entries are respectively the live tumor, necrotic
tumor and necrotic normal cells within each voxel at
time t (we use this notation throughout the text, please
see also the first paragraphs of the following section).
Let wt denote the sum of these vectors. Let Mmax denote
the N3 × 1 vector whose entries are all Mmax. We also
adopt the following notation: for a vector x and a num-
ber μ, the vector (x ≥ μ) is the binary vector with ele-
ments set to 1 if the corresponding element of x is ≥μ
and 0 otherwise. Finally, for any two vectors x and y let
x. ∗ y denote their element-wise product. The resulting
algorithm boils down to a simple vector algebraic
representation:
Vector s1 contains, for each voxel, the total number of
live (tumor and normal) cells that the particular voxel can
hold additional to its necrotic cells. In view of assumptions
(ii), (iv) and (v), s2 entries are numbers of live cancer cells
which already exist in each voxel that can also remain in
the respective voxel. In view of assumptions (iii) and (iv),
the vector (lt − s2) contains the numbers of live tumor cells
that lie within each respective voxel in excess of Mmax,
and therefore invade neighboring voxels by dislocating live
normal cells. The populations of live tumor cells at the
next time instant, i.e. after their diffusion to neighboring
voxels is given by the sum of s2 and Tc ∗ (lt − s2).
Of note, the entire approach again relies on the uni-
formity assumption, but this time for tumor cells. Ap-
parently, this is a simple, and definitely not the only way
to model the invasion of tumor cells. For the simulations
presented below, we will rely on it. More sophisticated
approaches could introduce randomness in the matrix
Tc exactly as described in section III; probabilities in Tc
could be dynamically readjusted by taking into account
nutrient quantities within each voxel, thereby introdu-
cing some at least rough, phenomenological notion of
chemotaxis in the model. However, our aim for the mo-
ment is to keep the presentation of the main ideas as
simple as possible. We will provide some suggestions for
further elaboration and implementation of this module
in the appendix.
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V. Proliferation/necrosis according to cell metabolism and
local availability of oxygen and glucose
In this section, we will study the proliferation of cells
within a voxel A. For a time interval equal to the time
step Δτ, we will neglect diffusion phenomena, and study
the proliferation and necrosis of cells within A as they
are dictated by the cells’ consumption needs and the
local availability of oxygen and glucose. Although special
effort has been made in order for the proposed approach
to be founded on a consensus of biological evidence, it is
definitely not the only one possible; somewhat different
assumptions may lead to different approaches. In section
VII, where we present the complete model architecture,
it will become apparent that the approach adopted here
can be completely readjusted, in order to consider differ-
ent assumptions.
For any voxel A, we will need the following variables:
- lt(A): number of living cancer cells within A at time
t.
- nct(A): number of necrotic cancer cells within A at
time t.
- nnt(A): number of necrotic normal cells within A at
time t.
The number of live normal cells within A at time t is
given by s(M − lt(A) − nct(A) − nnt(A)) where s(∙) is the
known function s(x) = x if x ≥ 0 and 0 if x < 0.
- ot(A): Oxygen quantity (pmols) within A at time t.
Initial value o0(A) is the same for every voxel, denoted
by o0. o0 is calculated such that the initial concentration
of oxygen in each voxel equals the concentration of dis-
solved oxygen in the blood (see section VI).
- glt(A): Glucose quantity (pmols) within A at time t. .
Initial value gl0(A) is the same for every voxel, denoted
by gl0. gl0 is calculated such that the initial concentration
of glucose in each voxel equals the concentration of glu-
cose in the blood (see section VI).
- o bt(A): sec) by the local vascular network within/
sec) by the local vascular network within A during the
previous time interval t−Δτ→ t
- gl_bt(A): Glucose supply rate (pmols/sec) by the local
vascular network within A during the previous time
interval−Δτ→t. The variables o_bt(A) and gl_bt(A) quan-
tify macroscopically the role of the local vascular net-
work in the provision of oxygen and glucose within each
voxel. We will assume that their values remain constant
during each time interval t→ t + Δτ. In fact, these vari-
ables are too subject to a dynamic time evolution due to
the effects of local vascular remodeling induced by the
tumor. We will discuss this matter in detail in the next
section. In this section, we will focus on the time interval
t→ t + Δτ, and aim at calculating the aforementioned
cell populations and chemical quantities at the next time
instant, i.e. t + Δτ. We note that the adopted notation
implies that o_bt + Δτ(A), gl_bt + Δτ(A) denote the oxygen
and glucose supply rates during the time interval under
consideration, i.e. t→ t + Δτ. In this section, these quan-
tities are assumed to be (pre)calculated by the algorithm
described in the next section.
We will further need the following parameters:
- M: average cell population capacity for each voxel.
- Ko: oxygen consumption rate (pmols/sec) of a normal
cell.
- Kgl: glucose consumption rate (pmols/sec) of a nor-
mal cell. Typically, for a normal cell acquiring its energy
mainly through combustion of glucose, Ko is 4 to 6 times
larger than Kgl [36, 37, 84].
- KATP: ATP consumption rate (pmols/sec) of a nor-
mal cell.
- λ: The product λKATP defines the ATP consumption
rate of an actively proliferating tumor cell. Since prolifer-
ating tumor cells consume much more resources than nor-
mal cells, λ should be >1 [39, 46, 85]. For quiescent tumor cells,
λ is assumed to be 1.
- cc: Cell cycle duration (sec).
- amax: maximum mitosis rate that tumor cells can
achieve, when they are not limited by local oxygen and
glucose levels. (mitoses/cell/ time step in secs).
Of note, concerning the initial values of o_bt(A) and
gl_bt(A) i.e. o_b0(A) and gl_b0(A), we will make the fol-
lowing assumption. For every voxel at time t = 0 the
provision of oxygen and glucose by the local vascular
network and their consumption by normal cells should
balance each other, such that the respective background
concentrations remain constant, i.e. o_b0(A) =MKo and
gl_b0(A) =MKgl [69, 71].
A normal cell’s ATP consumption is dictated by Ko,
Kgl and the stoichiometry of clean combustion and
glycolysis:
clean combustion : Gl þ 6O2 → 36 ATP
1
.
6
 	
Ko þ Ko→6Ko
glycolysis : Gl→2 ATP
Kgl−
1
.
6
 	
Ko→2Kgl−
1
.
3
 	
Ko
Thus, knowing Ko, Kgl allows us to explicitly determine
KATP= ð17
.
3
Þ Ko+ 2Kgl.
The stoichiometry of the clean combustion of glucose re-
quires that the glucose/oxygen uptake ratio is 1:6. It is well
documented that for cancer cells, due to increased
utilization of glycolysis, this is not the case [2]. Experimen-
tal measurements and estimations report that the ratio of
glucose /oxygen consumption in tumors can vary up to 1:1
or even more [14, 46, 86–88]. Compared to clean combus-
tion, glycolysis is 18 times less efficient in ATP production
and cancer cells compensate this deficiency by upregulating
glucose transporters, thereby increasing glucose import in
the cytoplasm. Considerably increased glucose uptake and
utilization has been reported in a variety of tumors by the
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use of positron emission tomography (PET) [2]. It has been
also reported that local levels of oxygen and glucose have
an effect on this ratio [86, 89]. Quantitative details of these
phenomena are still unclear. The possibility that a single
cell may employ both glycolysis and normal aerobic metab-
olism is not excluded. Qualitatively it seems evident that
when oxygen falls below a certain threshold, cells tend to
switch to a glycolytic phenotype. However, this observation
does not tell the whole story, since cancer cells switch to
glycolysis even when oxygen levels are abundant [90, 91].
To take account of this evidence from a modeling per-
spective, we take the following approach. We assume
that tumor cells within a voxel may obtain the energy
they need (i.e. λKATP pmols/sec) by acquiring a fraction
β of it by glycolysis and the remaining fraction by com-
bustion. This fraction will depend on the local availabil-
ity of oxygen and glucose, plus, we will introduce a
degree of randomness in it. Two additional, case-specific
parameters are the minimum and maximum values of
this fraction, which we respectively denote by β1 and β2.
Apparently, 0 ≤ β1 ≤ β ≤ β2 ≤ 1.
We have assumed that a quiescent tumor cell needs
KATP pmols ATP/sec to stay alive. From this amount
and according to the stoichiometry, βKATP pmols/sec
should come from glycolysis of βKATP/2 pmols/sec
glucose. The remaining (1 − β)KATP pmols/sec should
come from combustion of (1 − β)KATP/36 pmols/sec
glucose with (1 − β)KATP/6 pmols/sec oxygen. Thus, to
stay alive, a quiescent tumor cell needs
∙
17βþ 1
36
KATP pmol glucose=sec and
∙
1−β
6
KATP pmol oxygen=sec:
ð8Þ
On the other hand, an actively proliferating tumor cell
needs λKATP pmols ATP/sec. From this amount, βλKATP
pmols/sec should come from glycolysis of βλKATP/2
pmols/sec glucose. The remaining (1 − β)λKATP pmols/
sec should come from combustion of (1 − β)λKATP/36
pmols/sec glucose with (1 − β)λKATP/6 pmols/sec oxy-
gen. Thus, an actively proliferating tumor cell needs
∙
17βþ 1
36
λKATP pmol glucose=sec and
∙
1−β
6
λKATP pmol oxygen=sec:
ð9Þ
With the above evidence and assumptions in mind, we
devise the following algorithm, which will be executed
for each voxel A at each time step. The involved calcula-
tions require a detailed analysis, consisting of several
steps and subcases.
Step 1. In this step, we will calculate the following
quantities:
Oav: available oxygen for tumor cells in A during Δτ.
Glav: available glucose for tumor cells in A during Δτ.
nnt + Δτ(A): number of necrotic normal cells in A at the
next time instant.
First, we calculate the amount of oxygen and glucose
that will be available for tumor cells, by subtracting the
consumption of normal cells:
O1 ¼ ot Að Þ þ o btþΔτ Að Þ Δτ−s M−lt Að Þ−nct Að Þ−nnt Að Þð ÞKoΔτ
Gl1 ¼ glt Að Þ þ gl btþΔτ Að Þ Δτ−s M−lt Að Þ−nct Að Þ−nnt Að Þð ÞKglΔτ
Case 1.1: O1 ≥ 0 and Gl1 ≥ 0. In this case, oxygen and
glucose suffice for all normal cells in A to stay alive,
hence,
Oav ¼ O1
Glav ¼ Gl1
nntþΔτ Að Þ ¼ nnt Að Þ
Case 1.2: O1 < 0 or Gl1 < 0. This means that either oxy-
gen and/or glucose do not suffice for all normal cells in
A to stay alive. We calculate
Nn ¼ minðotðAÞþo btþΔτðAÞΔτKoΔτ ;
gltðAÞþgl btþΔτðAÞΔτ
KglΔτ
Þ , i.e. how
many living normal cells in A will stay alive.
Νn ¼ sðM−ltðAÞ−nctðAÞ−nntðAÞÞ−Nn , i.e. how many
normal cells in A will become necrotic.
In this case, the aforementioned quantities Oav, Glav
and nnt + Δτ(A) are
Oav ¼ ot Að Þ þ o btþΔτ Að ÞΔτ−NnKoΔτ
Glav ¼ glt Að Þ þ gl btþΔτ Að Þ Δτ−NnKglΔτ
nntþΔτ Að Þ ¼ nnt Að Þ þ Νn
Step 2. In this step, by taking into account the results
of Step 1, we will study the proliferation/necrosis of
tumor cells. Eventually, we will calculate the quantities
lt + Δτ(A), nct + Δτ(A), ot + Δτ(A), glt + Δτ(A). The quantity
nnt + Δτ(A) has been calculated in step 1.
Case 2.1: If lt(A) = 0, i.e. there are no living tumor cells
in the voxel, the calculation is simple:
ltþΔτ Að Þ ¼ lt Að Þ
nctþΔτ Að Þ ¼ nct Að Þ
otþΔτ Að Þ ¼ Oav
gltþΔτ Að Þ ¼ Glav
Case 2.2. If lt(A) > 0 the calculation is more elaborate.
Let a be the mitosis rate of tumor cells per time step Δτ,
i.e. the fraction of tumor cells within A that will divide
during Δτ and cc the duration of their cell cycle. The
duration of their cell cycle in time steps is cc/Δτ. Assum-
ing a uniform distribution of proliferating cells at all
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time steps of the cell cycle, we estimate a total number
alt(A)(cc/Δτ) of actively proliferating tumor cells. Some
stochasticity may be introduced in this estimate, but to
keep the presentation simple we will not go into details.
In view of (8) and (9), we define
Oc ¼ lt Að Þ 1−β6 ΚATPΔτ þ λ−1ð Þalt Að Þ cc=Δτð Þ
1−β
6
ΚATPΔτ
Glc ¼ lt Að Þ 17βþ 136 ΚATPΔτ þ λ−1ð Þalt Að Þ
 cc=Δτð Þ 17βþ 1
36
ΚATPΔτ
The quantities Oc and Glc are the amounts of oxygen
and glucose that will be needed by tumor cells in A in
order to proliferate with mitosis rate a. Those quantities
should be limited respectively by Oav and Glav, calcu-
lated from Step 1. Mathematically, this is expressed by
the inequalities Oc ≤Oav and Glc ≤Glav. These inequal-
ities require a closer examination and can be equiva-
lently written in the form
a≤
Oav−lt Að Þ 1−β6 ΚATPΔτ
λ−1ð Þalt Að Þ cc=Δτð Þ 1−β6 ΚATPΔτ
ð10Þ
a≤
Glav−lt Að Þ 17βþ 136 ΚATPΔτ
λ−1ð Þalt Að Þ cc=Δτð Þ 17βþ 136 ΚATPΔτ
ð11Þ
The inequalities (10) and (11) involve the -up to now
undetermined- variables a and β. They reflect the fact
that, for the tumor cells in A to proliferate with mitosis
rate a, a number β ∈ [β1, β2] should exist, such that a ≥ 0,
and (10), (11) are satisfied.
Investigation of (10): For each β ∈ [β1, β2] we define
the function
ao βð Þ ¼
Oav−lt Að Þ 1−β6 ΚATPΔτ
λ−1ð Þlt Að Þ cc=Δτð Þ 1−β6 ΚATPΔτ
For each given β ∈ [β1, β2], we observe the following:
10a) If ao(β) ≥ 0: ao(β) is the maximum mitosis rate
that the tumor cells can achieve for the specific β, sub-
ject solely to the limitations imposed by the available
oxygen in A.
10b) If ao(β) < 0, it is implied that Oav−ltðAÞ 1−β6 ΚATP
Δτ < 0: This means that for the specific β, no positive
mitosis rate can be achieved. In fact, available oxygen
does not suffice for all tumor cells in A to stay alive.
Furthermore:
10c) β = 1 means that tumor cells can acquire the en-
ergy they need relying solely on glycolysis. Note that
β→ 1 implies ao(β)→ +∞, reflecting the fact that in this
case, the proliferation of tumor cells is not limited by
the available oxygen.
10d) For each β ∈ [0, 1), ao(β) is an increasing function
of β.
10e) If a β ∈ [β1, β2] such that ao(β) ≥ 0 exists, it should
also satisfy
β≥1−
6Oav
ltðAÞKATPΔτ ≡ β
Since ao(β) is increasing, β is actually the lowest
number for which ao(β) ≥ 0. Hence,
 If β > β2, we have that for each β∈ [β1, β2] it
holds that ao(β) < 0. According to (10b), this means
that the available oxygen in A does not allow
proliferation and that not all tumor cells in A can
stay alive. Since β is the percentage with which
tumor cells rely on glycolysis, in this case, for any
proliferation to happen, the available oxygen
imposes greater reliance on glycolysis than the
maximum, i.e. β2.
 If β ≤β2, we have that for each β∈½ maxðβ ; β1Þ; β2
it holds that ao(β) ≥ 0
Investigation of (11): For each β ∈ [β1, β2] we define
the function
agl βð Þ ¼
Glav−lt Að Þ 17βþ 136 ΚATPΔτ
λ−1ð Þlt Að Þ cc=Δτð Þ 17βþ 136 ΚATPΔτ
For each given β ∈ [β1, β2], we observe the following:
11a) If agl(β) ≥ 0: ao(β) is the maximum mitosis rate
that the tumor cells can achieve for the specific β, sub-
ject solely to the limitations imposed by the available
glucose in A.
11b) If agl(β) < 0, it is implied that Glav−ltðAÞ 17βþ136
ΚATPΔτ < 0: This means that for the specific β, no posi-
tive mitosis rate can be achieved. In fact, available glu-
cose does not suffice for all tumor cells in A to stay
alive.
Furthermore,
11c) For each β ∈ [0, 1], agl(β) is a decreasing function
of β.
11d) If a β ∈ [β1, β2] such that agl(β) ≥ 0 exists, it should
also satisfy
β≤
1
17
36Glav
lt Að ÞΚATPΔτ −1
 
≡ β
Since agl(β) is decreasing, β is actually the highest
number for which agl(β) ≥ 0. Hence,
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 If β < β1, then for each β∈ [β1, β2] it holds that
agl(β) < 0. According to (11b), this means that the
available glucose in A does not allow proliferation
and that not all tumor cells in A can stay alive. Since
β is the percentage with which tumor cells rely on
glycolysis, in this case, for any proliferation to
happen, the available glucose imposes lower reliance
on glycolysis than the minimum, i.e. β1.
 If β≥β1, we have that for each β∈½β1; minðβ; β2Þ it
holds that ao(β) ≥ 0
We are now ready to complete Step 2:
Case 2.2.1. If β > β2 or β < β1 or minðβ; β2Þ < maxð
β ; β1Þ , the analysis above implies that for each β ∈ [β1,
β2], the available resources in A (oxygen and/or glucose)
do not suffice for all tumor cells in A to stay alive. We
proceed as follows:
We pick a random ~β ∈[β1, β2].
If ~β≠1 , the number of tumor cells that will remain
alive is given by
Nc ¼ min Oav
1−~β
6
 !
KATPΔτ
;
Glav
17~βþ 1
36
 !
KATPΔτ
0
BBBB@
1
CCCCA
If ~β ¼ 1 , the number of tumor cells that will remain
alive is given by
Nc ¼ Glav
17~βþ 1
36
 !
KATPΔτ
¼ 2Glav
KATPΔτ
In any case, the number of tumor cells that will be-
come necrotic is given by
Nc ¼ lt Að Þ−Nc
Hence, for the next time instant we have
ltþΔτ Að Þ ¼ Nc
nctþΔτ Að Þ ¼ nct Að Þ þ Nc
otþΔτ Að Þ ¼ Oav−Nc 1−
~β
6
 !
KATPΔτ
gltþΔτðAÞ ¼ Glav−Ncð
17~βþ 1
36
ÞKATPΔτ
Case 2.2.2. If β ≤β2 , β≥β1 and minðβ; β2Þ≥ maxðβ ;
β1Þ , i.e. the complement of the condition in Case 2.2.1
holds, according to the preceding analysis we have that
for each β∈½ maxðβ ; β1Þ; minðβ; β2Þ there exists a non-
negative mitosis rate a such that the inequalities Oc ≤
Oav and Glc ≤Glav are satisfied. Again, we pick a random
~β in ½ maxðβ ; β1Þ; minðβ; β2Þ.
If ~β≠1, the corresponding mitosis rate is
~a ¼ min
Oav−lt Að Þ 1−
~β
6
ΚATPΔτ
λ−1ð Þlt Að Þ cc=Δτð Þ 1−
~β
6
ΚATPΔτ
;
Glav−lt Að Þ 17
~βþ 1
36
ΚATPΔτ
λ−1ð Þlt Að Þ cc=Δτð Þ 17
~βþ 1
36
ΚATPΔτ
; amax
0
BB@
1
CCA
If ~β ¼ 1, the corresponding mitosis rate is
~a ¼ min
Glav−lt Að Þ 17
~βþ 1
36
ΚATPΔτ
λ−1ð Þlt Að Þ cc=Δτð Þ 17
~βþ 1
36
ΚATPΔτ
; amax
0
BB@
1
CCA
¼ min
Glav−
1
2
lt Að ÞΚATPΔτ
1
2
λ−1ð Þlt Að Þ cc=Δτð ÞΚATPΔτ
; amax
0
B@
1
CA
Hence, for the next time instant we have
ltþΔτ Að Þ ¼ lt Að Þ þ ~alt Að Þ
nctþΔτ Að Þ ¼ nct Að Þ
otþΔτ Að Þ ¼ Oav−lt Að Þ 1−
~β
6
ΚATPΔτ− λ−1ð Þ~alt Að Þ
 cc=Δτð Þ 1−
~β
6
ΚATPΔτ
gltþΔτðAÞ ¼ Glav−ltðAÞ
17~βþ 1
36
KATPΔτ−ðλ−1Þ~altðAÞ
 ðcc=ΔτÞ 17
~βþ 1
36
KATPΔτ
This concludes our analysis. Το summarize, tumor
cells may be able to rely on glycolysis within certain
limits, i.e. β1 and β2, but these limits may become nar-
rower by the available quantities of glucose and oxygen;
in that case, the ability of tumor cells to proliferate with
high mitosis rates is impaired. Mathematically, this is
reflected by the decreased probability to attain high mi-
tosis rates, or even the inability of tumor cells to stay
alive.
We note that the calculation of Oav and Glav in Step 1
implies that normal cells are the first to fulfill their
needs by the existing resources. This is certainly not ac-
curate; again, a more realistic approach would be to
introduce some randomness in the percentage of re-
sources that would be available for normal versus tumor
cells. Α random number roughly proportional to the
ratio normal/tumor cells in the voxel may be a reason-
able choice.
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VI. The effects of tumor-induced vascular remodeling
In this section, we will propose a method to quantify the
effects of tumor-induced vascular remodeling, in terms
of how it affects the local provision of oxygen and glu-
cose by the vascular system. The quantification we
propose is based on the basic physiology of the vas-
cular network plus additional biological observations
regarding how it is affected by tumor growth.
Ideally, the vascular network works like a buffer of nu-
trients, in our case, oxygen and glucose. If, at a specific
time instant, the concentration of a substance dissolved
in the blood is higher than the respective concentration
in the surrounding tissue, the substance diffuses through
the vessel walls towards the tissue until the two concentra-
tions are equal, and vice versa. The speed of this diffusion
process as well as the capability of the local vascular network
to quickly balance these concentrations is limited by the ves-
sel density and total surface of the blood vessel walls in the
region under consideration [92].
In our model, we will assume that the concentrations
of dissolved oxygen and glucose in the blood are con-
stant. In a voxel A of specific volume, these concentra-
tions correspond to quantities of oxygen and glucose
within A, which we denote by o0 and gl0 . If at a specific
time t, the quantity of say, oxygen in A i.e. ot(A) is lower
(higher) than o0 , this implies that the concentration of
oxygen in A is lower (higher) than the concentration of
dissolved oxygen in the blood. Hence, the provision of
oxygen in A i.e. o_bt(A) should increase (decrease) to
level this imbalance. We model this increase (decrease)
during each time step by a random fraction of the quan-
tity ðð o0−otðAÞ Þ=ΔτÞ. The respective quantity ðð gl0−gltð
AÞ Þ=ΔτÞ is used for glucose. This results in the follow-
ing equations:
o btþΔτ Að Þ ¼ o bt Að Þ þ r1 o0−ot Að Þð Þ=Δτð Þ
gl btþΔτ Að Þ ¼ gl bt Að Þ þ r2 gl0−glt Að Þ
 
=Δτ
 
where o_bt + Δτ(A), gl_bt + Δτ(A) are the oxygen and
glucose supply rates (pmols/sec) by the local vascular
network within A during the time interval t→ t + Δτ.
The quantities o_bt(A) and gl_bt(A) are the respect-
ive supply rates during the previous time interval,
i.e. t − Δτ→ t. The numbers r1 and r2 are random
numbers uniformly distributed in the interval [0, 1].
We note that o_bt(A) and gl_bt(A) may take nega-
tive values. This simply reflects the fact that when
the respective substance concentration in A is higher
than the one in the blood and the consumption of
the substance within A is low enough, diffusion may
happen towards the vessels, decreasing thereby the
substance quantity in the surrounding tissue.
It is clear, however, that o_bt(A) and gl_bt(A) can-
not grow unboundedly neither towards positive nor
towards negative values. As previously mentioned,
they are limited by the local vessel density and total
surface of the blood vessel walls in A. A detailed
quantitative analysis addressing the pertinent mecha-
nisms would render the model extremely complex.
We therefore opt for a more macroscopic approach.
In [93] a maximum value of oxygen consumption for
normal mammalian cells is given. From this, an upper
bound for the absolute value of o_bt(A) can be deduced.
Assuming that in the tissue under consideration, normal
cell metabolism does not change and utilizes oxygen and
glucose in a steady ratio, we can deduce a similar bound
for the absolute value of gl_bt(A). We denote these two
constant numbers by o_b_max and gl_b_max. In normal
tissue, these numbers remain constant and are the same
for each voxel. In our case, however, these bounds may
be different for each voxel and are subject to a temporal
evolution, inflicted by the tumor-induced vessel regres-
sion and angiogenesis. To address this in our model, we
introduce the N3 × 1 vectors o_b_maxt and gl_b_maxt.
Consistent with our previous notation, o_b_maxt(A) and
gl_b_maxt(A) denote the aforementioned bounds for the
voxel A during the time interval t − Δτ→ t. For each
voxel A, the initial values of o_b_maxt(A) and gl_b_
maxt(A) at time t = 0 are respectively the constants o_b_
max and gl_b_max. Essentially, o_b_maxt(A) and gl_b_
maxt(A) quantify the capacity of the vascular network
within A to provide/absorb molecules to/from the sur-
rounding tissue, leveling thereby the concentration imbal-
ances between blood and tissue. A disorganized and
regressed vascular network in A implies lower values for
o_b_maxt(A) and gl_b_maxt(A), as is usually the case in
the interior of a tumor. A robust, dense vascular network
in A implies higher values for o_b_maxt(A) and gl_b_
maxt(A), as is the case for the outer proliferating rim of a
tumor.
In what follows, we will use the temporal evolution
of these quantities in each voxel to quantify the ef-
fects of tumor-induced vascular remodeling on the
local provision/absorption of nutrients. We start
from some basic biological background.
It is well documented, that as tumors grow, they co-opt
and affect the pre-existing host vasculature by a number of
ways, for which the collective term tumor-induced vascular
remodeling is commonly used. Tumor-induced vascular
remodeling consists in several mechanisms, including vessel
occlusion, disintegration, and new vessel creation. The lat-
ter is most commonly referred as tumor-induced angiogen-
esis, and results in a tortuous, highly irregular vascular
network [4, 6, 7].
In [94, 95] the authors observed that cancer cells
initially co-opt host existing vasculature and grow as
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well vascularized tumors for several days, up to 2
mm in diameter. No evidence of angiogenesis is ob-
served during this period. Progressively, blood vessels
near the tumor core start to regress and/or become
occluded, while tumor periphery displays robust
angiogenesis. Later work in [96, 97] demonstrated
that this pattern repeats itself during later stages of
tumor growth; once the tumor grows over a well
vascularized region, local vasculature starts to re-
gress. At the same time, tumor periphery displays
high angiogenic activity, thereby further promoting
tumor growth.
The exact biological mechanisms pertaining to these
phenomena are not well understood. Generally, they
are attributed to a variety of complex molecular and
biomechanical interactions between existing vascula-
ture and tumor cells. It is evident, however, that
tumor-induced vascular remodeling affects the local
supply of nutrients in tumors and this is where we
are going to focus. Taking into consideration the
aforementioned evidence, we will try to quantify the
spatiotemporal evolution of local oxygen and glucose
provision, i.e. the vectors o_bt , gl_bt , o_b_maxt and
gl_b_maxt
Since tumor-induced vascular remodeling occurs
either in the interior or in the close vicinity of a
tumor, at each time step we consider only the voxels
that have already been reached by the tumor, that is,
voxels for which lt(A) + nct(A) > 0. Let A denote such
a voxel.
According to the aforementioned evidence, vessel
regression should decrease o_b_maxt(A) and gl_b_
maxt(A). As the occupation of A by tumor cells (live
or necrotic) increases, the vessel regression rate
should also increase, and hence, o_b_maxt(A) and gl_
b_maxt(A) should decrease at a higher rate.
On the other hand, angiogenesis should increase o_b_
maxt(A) and gl_b_maxt(A). A lower occupation of A by
live tumor, necrotic tumor and necrotic normal cells,
implies a higher angiogenesis rate and hence, a higher
rate by which o_b_maxt(A) and gl_b_maxt(A) increase.
Furthermore, tumor angiogenesis is most commonly
associated with nutrient deficit, i.e. when oxygen or glu-
cose quantities fall below certain thresholds known re-
spectively as hypoxia and hypoglycemia thresholds.
Typical values for these thresholds are 0.30* o0 and 0.50*
gl0 [5, 37, 98]. We introduce an additional N
3 × 1 logical
vector, denoted by swt with the following use: at the end
of each time step, for each voxel A, the quantities ot(A)
and glt(A) are compared with their respective thresholds;
if either of them is below its threshold and the voxel
contains live tumor cells, swt(A) is set to 1, indicating
that angiogenesis is on for this voxel. Otherwise, swt(A)
is set to 0.
Let vr and ve denote the maximum rates by which
the capacity of the vascular network in A to provide/
absorb molecules to/from the surrounding tissue (as
modeled by o_b_maxt(A) and gl_b_maxt(A)) de-
creases or increases, respectively. The orders of mag-
nitude of the corresponding half- and doubling times
can be deduced from [94, 95] and are in the order
of days.
According to the aforementioned biological evidence
and assumptions, a general way to quantify the timely
evolution of the macroscopic variables under consider-
ation is
ob maxtþΔτðAÞ ¼
ð1− f rðltðAÞ; nctðAÞÞvr þ swtðAÞ f eðltðAÞ; nctðAÞ;
nntðAÞÞveÞ  ob maxtðAÞ
glb maxtþΔτðAÞ ¼
ð1− f rðltðAÞ; nctðAÞÞvr þ swtðAÞ f eðltðAÞ; nctðAÞ;
nntðAÞÞveÞ  glb maxtðAÞ
where fr(lt(A), nct(A)) and fe(lt(A), nct(A), nnt(A)) are
functions taking values in [0, 1]. Function fr(lt(A), nct(A))
is increasing in both of its arguments. Function fe(lt(A),
nct(A), nnt(A)) is decreasing in all three of its arguments.
These deterministic equations constitute only a
rough approximation of the involved dynamics. For a
more robust approach, we introduce randomness in
them in the following way. Since vr and ve are the
maximum rates of vessel regression/expansion, at
each time step, and for each voxel A which has been
reached by the tumor, we pick two random numbers
r3 and r4 in the interval [0, 1] and introduce the more
general, stochastic equations
ob maxtþΔτðAÞ ¼
ð1− f rðltðAÞ; nctðAÞÞr3vr þ swtðAÞ f eðltðAÞ; nctðAÞ;
nntðAÞÞr4veÞ
ob maxtðAÞ
glb maxtþΔτðAÞ ¼
ð1− f rðltðAÞ; nctðAÞÞr3vr þ swtðAÞ f eðltðAÞ; nctðAÞ;
nntðAÞÞr4veÞ
glb maxtðAÞ
It remains to choose the functions fr and fe. Since
the monotonicity of these functions is determined, it
remains to choose their shape, i.e. linear, convex or
concave. For the simulations presented below, we
have chosen functions of linear shape. Putting
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everything together, to calculate o_b_maxt + Δτ(A) and
gl_b_maxt + Δτ(A) we will use the equations
ob maxtþΔτðAÞ ¼
ð1− ltðAÞ þ nctðAÞ
M
r3vr þ swtðAÞ
M−ltðAÞ−nctðAÞ−nntðAÞ
M
r4veÞ
ob maxtðAÞ
glb maxtþΔτðAÞ ¼
ð1− ltðAÞ þ nctðAÞ
M
r3vr þ swtðAÞ
M−ltðAÞ−nctðAÞ−nntðAÞ
M
r4veÞ
glb maxtðAÞ
We note that algorithmically, before each such calcula-
tion, a sanity check should be performed for the each of
the quantities ltðAÞþnctðAÞM and
M−ltðAÞ−nctðAÞ−nntðAÞ
M ensuring
that their values stay respectively below 1 and above 0.
To summarize, to model the effects of tumor-induced
vascular remodeling, we introduced two additional vec-
tors, that is, two additional variables for each voxel A,
namely o_b_maxt(A) and gl_b_maxt(A). These variables
quantify the maximum values the local provision/ab-
sorption of oxygen and glucose may attain, i.e. the max-
imum absolute values of o_bt(A) and gl_bt(A) reflecting
thereby the capacity of the local vascular network to
provide/absorb molecules to/from the surrounding tis-
sue. The spatiotemporal evolution of these variables re-
flects the effects of vessel regression and angiogenesis
induced by the tumor. The resulting algorithm applied
at each time step for each voxel A follows:
Note: For any positive number μ and xϵ ℝ we will
make use of the function
Bμ xð Þ ¼
−μ; x < −μ
x;−μ≤x≤μ
μ; x > μ
8<
:
Case 1: If lt(A) = nct(A) = 0 that is, the tumor has not
yet reached A. In this case, the maximum absolute
values of oxygen and glucose provision/absorption dur-
ing the time step t→ t + Δτ simply equal the ones during
the previous time step, t − Δτ→ t:
o b maxtþΔτ Að Þ ¼ o b maxt Að Þ
gl b maxtþΔτ Að Þ ¼ gl b maxt Að Þ
We pick two random numbers r1, r2, uniformly dis-
tributed in [0, 1]. The actual provision/absorption for
oxygen and glucose by the vascular system during time
interval t→ t + Δτ is calculated by
o btþΔτ Að Þ ¼ Bo b maxtþΔτ Að Þ o bt Að Þ þ r1 o0−ot Að Þð Þ=Δτð Þð Þ
gl btþΔτ Að Þ ¼ Bo b maxtþΔτ Að Þ gl bt Að Þ þ r2 gl0−glt Að Þ
 
=Δτ
  
Case 2: If lt(A) + nct(A) > 0 that is, the tumor has
reached A. We first pick two random numbers r1, r2,
uniformly distributed in [0, 1] and calculate
o btþΔτ Að Þ ¼ o bt Að Þ þ r1 o0−ot Að Þð Þ=Δτð Þ
gl btþΔτ Að Þ ¼ gl bt Að Þ þ r2 gl0−glt Að Þ
 
=Δτ
 
Again, we pick two random numbers r3, r4 uniformly
distributed in [0, 1]. The upper bounds for the absolute
values of o_bt + Δτ(A) and gl_bt + Δτ(A) are given by
ob maxtþΔτðAÞ ¼
ð1− ltðAÞ þ nctðAÞ
M
r3vr þ swtðAÞ
M−ltðAÞ−nctðAÞ−nntðAÞ
M
r4veÞ  ob maxtðAÞ
glb maxtþΔτðAÞ ¼
ð1− ltðAÞ þ nctðAÞ
M
r3vr þ swtðAÞ
M−ltðAÞ−nctðAÞ−nntðAÞ
M
r4veÞ  glb maxtðAÞ
The provision/absorption for oxygen and glucose by
the vascular system during time interval t→ t + Δτ is cal-
culated by
o btþΔτ Að Þ ¼ Bo b maxtþΔτ Að Þ o btþΔτ Að Þ
 	
gl btþΔτ Að Þ ¼ Bgl b maxtþΔτ Að Þ gl btþΔτ Að Þ
 	
VII. The complete model architecture. Modularity and
adjustability
The model we propose can be seen as a discrete time
dynamical system. The state of the system consists of
the nine N3 × 1 vectors lt, nct, nnt, ot, glt, o_bt, gl_bt, o_b_
maxt and gl_b_maxt
In sections I-VI we have defined the following
operators.
 The operator defined in section VI, which we
denote by Fvr. Applying this operator to the state
vector consists in applying the algorithm described
in the last section for each voxel. This operator
calculates the supply rate of oxygen and glucose
during the time interval t→ t + Δτ from the
respective values during the previous time interval, t
− Δτ→ t, as it is dictated by the effects of tumor-
induced vascular remodeling.
 The operator defined algorithmically in section V,
which we denote by Fpn. Applying operator Fpn to
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the state vector, consists in checking all cases
described in section V and performing the respective
calculations for each voxel in the lattice. This
operator calculates the proliferation/necrosis of cells
in each voxel, as they are dictated by the
voxels’ oxygen and glucose levels and supply rates.
 The operators defined in section III, which we
denote by Fo, Fgl . Applying each of these operators
to the state vector consists in multiplying the
matrices (To or Tgl) with the respective vector ot or
glt, thereby calculating how chemical fields change
due to diffusion.
 The operator defined algorithmically in section IV,
which we denote by Fc. Applying the operator Fc to
the state vector consists in executing Algorithm 2,
calculating thereby how cancer cell populations
within each voxel change due to cell diffusion.
Knowledge of the state vector at time t allows us to
calculate the state vector at time t + Δτ, by applying the
algorithm depicted in Fig. 2.
Phenomena pertaining to tumor-induced vascular
remodeling, nutrient consumption, cell proliferation
and cellular or molecular diffusion are modeled by
separate operators (i.e. algorithmic modules), applied
sequentially to the state vector. Within the proposed
methodology, the algorithmic modules corresponding
to operators Fpn, Fvr are completely re-adjustable.
This facilitates the simulation of scenarios based on
different hypotheses concerning the effects of tumor-
induced vascular remodeling on nutrient supply rates,
cell proliferation, necrosis and metabolism of chem-
ical species. A variety of choices is also available for
re-adjusting Fc; we provide some suggestions in the
appendix. Introduction of additional diffusion opera-
tors like Fo and Fgl and extension of operators Fpn
and Fvr enables the consideration of additional chem-
ical species such as lactate, growth factors and che-
motherapeutic agents. Gradual removal of necrotic
cells from the tumor mass may (and should) also be
considered. Introduction of additional cellular species
is also feasible, by considering additional cellular dif-
fusion operators and appropriate readjustment of Fpn.
Of note, there is a large disparity between the time
scales of chemical and cellular diffusion, with the latter
evolving much more slowly. The diffusion coefficients of
oxygen and glucose are in the order of 10−5 cm2/sec
while the respective coefficient for tumor cells is in the
order of 10−8 cm2/sec. Furthermore, tumor cell diffusion
in neighboring voxels is also affected by their prolifera-
tion. This allows applying Fc to the state vector every
several time steps κ; for the simulations presented in the
next section, we used a time step Δτ= 10 s and κ= 30
(i.e. 5 mins).
The methodology we described in the previous sec-
tions essentially casts the problem of modeling tumor
Fig. 2 The complete model architecture
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growth in the realm of spatially distributed, stochastic
dynamical systems. The state of the system evolves
according to a law of the form xk + 1 = f(xk) where the
transition xk→ xk + 1 is stochastic and x has an additional
spatial structure.
The model was implemented by making extensive use
of MATLAB’s vectorized approach to coding. We note
that apart from the operators Fo, Fgl and Fc, this vectorized
implementation is feasible also for the operators Fvr and
Fpn. However, to keep the code readable, in this work we
have opted to implement Fvr and Fpn using loops. Al-
though in the present work we did not exploit multicore
computation, it is clear that each of the aforementioned
algorithmic operators is eligible for parallel implementa-
tion. Furthermore, vectorized implementation of the
resulting algorithmic modules opens the road for exploit-
ing the capabilities of modern tools like Python’s Numba
compiler or TensorFlow for computation on GPUs. This
will facilitate simulations over larger tissue areas with finer
spatial and temporal resolutions, plus, importantly, a com-
parative analysis of the numerical error induced by the
discretization parameters. We note that such an analysis
has not been performed yet, since it requires the consider-
ation of more and smaller values for Δs and Δt. This, how-
ever, increases significantly the computational burden of
each simulation, and requires a completely different im-
plementation of the model in terms of programming. It is
therefore left for future work.
VIII. Simulations and use cases
In this section, we use the model developed in the previ-
ous sections for a theoretical study of tumor growth,
consisting of two parts. First, we use the model to
visualize various aspects of tumor expansion. The result-
ing images are qualitatively compared with pertinent
biological observations. We then perform a multivariate
analysis regarding the effects of a subset of model pa-
rameters on the number of live cancer cells after a
certain period of free growth.
The proposed model can be used for visualizing vari-
ous phenomena encountered during the expansion of a
tumor. Figures 3, 4, 5, 6, 7, 8, 9, 10, 11 and 12, which we
explain below, depict a series of such examples. These
images are snapshots of a simulation with the following
parameter values (see also sections about metabolism
and tumor-induced vascular remodeling above). Max-
imum mitosis rate for cancer cells amax was set such that
their minimum doubling time is 5 days. Parameter
lambda is set λ = 10.
Fig. 3 Visualization of tumor growth at the 70th day
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Fig. 4 Visualization of tumor growth at the 90th day
Fig. 5 Visualization of tumor growth at the 70th day, vertical section
Antonopoulos et al. BMC Bioinformatics          (2019) 20:442 Page 18 of 36
Fig. 6 Visualization of tumor growth at the 90th day, vertical section
Fig. 7 Oxygen levels per voxel at the 70th day. Darker color implies lower oxygen
Antonopoulos et al. BMC Bioinformatics          (2019) 20:442 Page 19 of 36
Fig. 8 Oxygen levels per voxel at the 90th day. Darker color implies lower oxygen
Fig. 9 Glucose levels per voxel at the 70th day. Darker color implies lower glucose
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Fig. 10 Glucose levels per voxel at the 90th day. Darker color implies lower glucose
Fig. 11 Capacity of the vascular network per voxel to provide/absorb nutrients to/from the surrounding tissue, 70th day
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Maximum vasculature regression rate (vr) was set such
that the corresponding minimum halftime time is 5 days.
Maximum vasculature expansion rate (ve) was set such
that the corresponding minimum doubling time is 1 day.
A spatially constant, synthetic diffusion tensor was used
for the diffusion of live cancer cells, defined by the
orthonormal vectors
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appearing in equation (5) were calculated from the equa-
tion 2D = aλ derived in [80]. The value range for the cell
diffusion coefficient D was chosen according to the esti-
mations made in [99]. The quantity
ﬃﬃﬃﬃﬃﬃﬃ
αλ1
p
was set much
higher than
ﬃﬃﬃﬃﬃﬃﬃ
αλ2
p
and
ﬃﬃﬃﬃﬃﬃﬃ
αλ3
p
, such that the diffusion of
live cancer cells occurs primarily along the first vector.
Table 1 summarizes parameter values used for the simu-
lations of this section. An initial population of 5 ∙ 105
live cancer cells was placed in the center of the simu-
lated region.
Figs. 3 and 4 depict the tumor at the 70th and 90th day
of the simulation, respectively. A general observation, hold-
ing for all performed simulations was that the chosen cell
diffusion tensor affects the overall tumor shape in a notice-
able way. This is depicted in Fig. 3, where the tumor shape
is roughly similar to the ellipsoid of the diffusion tensor de-
fined above. It can also be seen in Fig. 4, where the depicted
tumor appears to be an approximately conformal expansion
of the tumor in Fig. 3, although markedly distorted by the
underlying stochasticity.
In Figs. 5 and 6, vertical sections of these tumors are
shown, taken at the central (11th) voxel plane of the lattice.
All colored voxels have been reached by the tumor, i.e. they
contain a nonzero population of live plus necrotic cancer
cells. We do not show voxels containing only host necrotic
cells, something that was often observed in the near vicinity
of the tumor periphery. We remind the reader that M is
the average cell population capacity per voxel. The color
code is as follows. Cyan voxels contain a total population of
live tumor, necrotic tumor and necrotic host cells that does
not exceed 50% of M. Where this quantity is above 50% of
M, voxels are colored blue, gray or black, depending on the
amount of necrotic cells they contain. Specifically, in blue
voxels, the total necrotic (tumor+host) cell population is
below 65% of M. In gray voxels, the total necrotic cell
population is between 65 and 95% of M. In black voxels,
necrotic cells are above 95% of M. Note that in both Figs. 5
and 6 necrosis is higher towards the tumor center. This is
in agreement with the general observation that after some
period of growth, due to vasculature disorganization and
limited diffusion of nutrients near the tumor center, a nec-
rotic core is formed; viable proliferating cells are located
mainly at the outer rims of a tumor.
Figs. 7 and 8 depict a profile of the oxygen levels per
voxel, corresponding to the vertical sections shown in
Figs. 5 and 6, respectively. The darker the voxel shade,
Fig. 12 Capacity of the vascular network per voxel to provide/absorb nutrients to/from the surrounding tissue, 90th day
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the lower the oxygen quantity in the specific voxel. The
lightest shade indicates a voxel whose oxygen level is at
least equal to normal. The darkest shade indicates a
voxel whose oxygen level is below 15% of normal tissue
level. The same color code holds for Figs. 9 and 10,
which depict the respective glucose levels. Note that the
tumor interior contains both hypoxic and hypoglycemic
regions. From the simulations performed, hypoxic re-
gions appeared to be much more spatially inhomogen-
eous and time varying than hypoglycemic ones, which
generally tended to appear more congruent with necrotic
areas of the tumor and overall tumor shape. Other than
that, the shape of both hypoxic and hypoglycemic re-
gions appeared to be largely random, and no pertinent
spatial patterns were detected.
Similarly, Figs. 11 and 12 depict a similar profile of
o_b_maxt for each voxel, corresponding respectively
to the vertical sections shown in Figures 5 and 6. We
remind the reader that, for a voxel A, o_b_maxt(A)
quantifies the capacity of the vascular network within
A to provide/absorb oxygen to/from the surrounding
tissue, thereby reflecting the regressed or expanded
vasculature in A (see also section VI). The color code
for Figs. 11 and 12 is as follows: The darkest gray-
scale shade indicates that for the respective voxel A,
the value of o_b_maxt(A) is below 50% of its value in
normal tissue. The lightest grayscale shade indicates
that for the respective voxel A, the value of o_b_
maxt(A) is equal to its value in normal tissue. Ma-
genta indicates that o_b_maxt(A) is between 100 and
125% of its value in normal tissue. Blue indicates that
o_b _maxt(A) is between 125 and 150% of its value in
normal tissue. We note that since o_b_maxt and gl_
b_maxt evolve temporally in the same way (see sec-
tion VI), using the same color code yields identical
figures for gl_b_maxt. Figures 11 and 12 depict that
towards the tumor center, o_b_maxt is lower, i.e. vas-
culature appears to be more regressed. Tumor
Table 1 Simulation parameters
Parameter Symbol Value References and remarks
Lattice size N 21
Time step Δτ 10 s
Voxel edge Δs 2 mm
Average cell population capacity for each voxel M 8 ∙ 106 cells [74]
Maximum cell population capacity for each voxel Mmax 1.02M Assumed (see also appendix)
Oxygen Diffusion Coefficient Do 1.8 ∙ 10
−5 cm2/sec [14, 52, 53]
Glucose Diffusion Coefficient Dgl 1.05 ∙ 10
− 5 cm2/sec [14, 52, 53]
Cell diffusion Coefficient Dc 1.5 ∙ 10
− 8 to 1.5 ∙ 10− 6
cm2/sec
[56, 99]
Maximum mitosis rate amax 16 ∙ 10
− 6 mitoses/cell/
10 s
Corresponding to a doubling time of 5 days in
ideal chemical conditions
Cell cycle duration cc 24 h [36, 37]
Quiescent host cell Oxygen consumption Ko 250 ∙ 10
− 6 pmol/sec [36, 37, 84]
Quiescent host cell Glucose consumption Kgl 50 ∙ 10
− 6 pmol/sec [36, 37, 84]
Maximum absolute value of oxygen provision/absorption by
local vasculature in normal tissue
o_b_
max
2.8 ∙ 103 pmol/sec Estimated by values given in [93]
Maximum absolute value of glucose provision/absorption by
local vasculature in normal tissue
gl_b_
max
560 pmol/sec Estimated by values given in [93]
Maximum vasculature expansion rate ve 1.6 ∙ 10
−5-8 ∙ 10− 5 Corresponding to minimum doubling time
ranging from 5 to 1 days
Maximum vasculature regression rate vr 1.6 ∙ 10
−5-8 ∙ 10− 5 Corresponding to minimum halftime ranging
from 5 to 1 days
Hypoxia threshold percentage ho 30% of oxygen level in
normal tissue
[5, 37]
Hypoglycemia threshold percentage hgl 50% of glucose level in
normal tissue
[37, 98]
Oxygen per voxel in normal tissue o0 1.2 ∙ 10
3 pmol [45, 92] corresponding to concentration in
capillary blood.
Glucose per voxel in normal tissue gl0 40 ∙ 10
3 pmol [45, 92] corresponding to concentration in
capillary blood.
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Fig. 13 Tumor growth absent angiogenensis
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Fig. 14 Tumor growth for 0≤ β ≤ 0.1, i.e. the tumor acquires energy mainly through combustion of glucose
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Fig. 15 Tumor growth for 0.1≤ β ≤ 0.2, i.e. glycolysis is utilized more that in the respective cases of Figure 14
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Fig. 16 Tumor growth for 0.2≤ β ≤ 0.3, i.e. glycolysis is utilized more that in the respective cases of Fig. 15
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Fig. 17 Tumor growth for 0.3≤ β ≤ 0.4, i.e. glycolysis is utilized more that in the respective cases of Fig. 16
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Fig. 18 Tumor growth for 0.4≤ β ≤ 0.5, i.e. glycolysis is utilized more that in the respective cases of Fig. 17
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periphery displays values larger than normal, reflect-
ing the fact that at the outer rims of the tumor,
angiogenesis takes place at a much faster rate than
vessel regression.
As a more general use case, we performed a multivari-
ate analysis on the effects of certain tumor growth re-
lated parameters on the number of viable tumor cells
after a period of free growth. Specifically:
 Maximum mitosis rate for cancer cells amax was
fixed such that the corresponding minimum
doubling time is 5 days.
 Parameter λ was varied in the set {2,4,6,8,10}. We
remind the reader that λKATP is the ATP
consumption rate of an actively proliferating tumor
cell, where KATP is the ATP consumption rate of a
normal host cell.
 The parameters β1 and β2, i.e. the minimum and
maximum values of the energy fraction cancer cells
acquire by glycolysis were varied in the set [β1 β2]
={[0 0.1], [0.1 0.2], [0.2 0.3], [0.3 0.4], [0.4 0.5]}
 Vasculature regression minimum halftime (in days)
was varied in {1,2,3,4,5}.
 Vasculature expansion minimum doubling time (in
days) was varied in {1,2,3,4,5}. The case where no
angiogenesis occurred throughout the entire
simulation was also considered.
The initial tumor population was 5 ∙ 105 live cancer
cells. The evolution of these tumors was simulated for a
time period of 90 days. Due to the stochasticity of the
model, for each set of parameter values a total of 20 sim-
ulations was performed. The results of these simulations
are shown in Figs. 13, 14, 15, 16, 17, and 18.
In each of the Figs. 13, 14, 15, 16, 17, and 18, the col-
umns ‘lambda’,‘Vasculature regression minimum half-
time’ and ‘Vasculature expansion minimum doubling
time’ are self-explanatory. Each row of the column ‘Live
cancer cells after 90 days’ depicts the respective numbers
of live tumor cells for each one of the 20 simulations
performed for the parameters specified in the previous
columns of the same row. In each row, these 20 num-
bers are drawn as horizontal lines, each one with length
proportional to the resulting number of live cancer cells
after 90 days. These 20 lines are drawn in sorted order
with regard to their length, from longest (top) to short-
est (bottom), and form the skewed bar observed in each
row of the ‘Live cancer cells after 90 days’ column. We
note that due to the smaller final populations observed
absent angiogenesis, the aforementioned lines in Fig. 13
are drawn in a different scale than in Figs. 14, 15, 16, 17,
and 18. In each row of the column ‘Probability of tumor
survival’, we provide the fraction of simulations (out of
the 20 simulations performed for the parameters of the
specific row) that resulted to a nonzero population of
live cancer cells. Each row of the column ‘Expected
number of live cancer cells’ provides the expected num-
ber of live cancer cells after 90 days, conditioned on the
survival of the tumor. This is essentially the mean of the
resulting final populations, calculated by taking into ac-
count only the simulations that resulted in a nonzero
final population of live cancer cells.
As explained above, each row of the ‘Live cancer cells
after 90 days’ column depicts a skewed bar, formed by
the final populations of live cancer cells for each of the
20 simulations performed for the specific row. Thus, the
skewness of each such bar indicates the variance ob-
served in the results of the respective simulations. For
each such bar, a flatter right end indicates a lower vari-
ance; a more skewed right end indicates a higher vari-
ance. Visual inspection of these bars indicates that in
most cases (i.e. rows), 20 simulations can provide a rea-
sonable overview of the potential outcomes. However,
there are cases where the skewness of the aforemen-
tioned bars is quite high, indicating a higher variance in
the potential outcomes of the respective simulations. In
such cases, like for example, the case in Fig. 13 where
0.1 ≤ β ≤ 0.2, lambda = 2 and Vasculature regression
minimum halftime = 4 days or the same case but with
lambda = 4, it is evident more simulations are needed. In
general, our analysis showed that simulation parameters
have an effect not only on the probability of survival and
expected populations of cancer cells, but also, in several
cases, on the variance of these populations. This was also
observed for intermediate time points, i.e. cell popula-
tions calculated at time points within the overall time
frame of 90 days.
Fig. 13 depicts the results of these simulations when
tumors grow without angiogenesis. We see that the
limits of the energy fraction β cancer cells can acquire
from glycolysis play a crucial role on tumor growth and
survival. For 0 ≤ β ≤ 0.1, i.e. when cells employ mainly
combustion of glucose, tumors survive essentially only if
they have minimal energy needs compared to host cells,
and additionally, if vasculature regression evolves at a
minimal rate. For 0.1 ≤ β ≤ 0.2, tumors survive in more
cases than for 0 ≤ β ≤ 0.1 and in these cases they reach
large end populations of viable cancer cells. For 0.2 ≤ β ≤
0.3 tumors survive in even more cases, but don’t reach
end populations as large as for 0.1 ≤ β ≤ 0.2. For 0.3 ≤ β ≤
0.4 tumors survive almost like in the case where
0.2 ≤ β ≤ 0.3, although with lower probabilities and lower
end populations. The same trend is observed when mov-
ing to the last case; for 0.4 ≤ β ≤ 0.5 tumors survive in
slightly less cases than for 0.3 ≤ β ≤ 0.4, with lower prob-
abilities and lower end populations. In each separate
case, maximum vasculature regression rate (i.e. mini-
mum halftime) and cancer cell energy requirements
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affect both probability of survival and final number of
viable cells. In fact, in each case, the higher the max-
imum rate of vasculature regression, the lower are both
the survival probability and the viable end population.
Furthermore, in each case, for the same maximum rate
of vasculature regression, higher energy requirements by
tumor cells imply lower survival probabilities and viable
end populations.
Figures 14, 15, 16, 17, and 18 consider additionally the
effects of vasculature expansion. Visual inspection of these
Figures shows that the limits of β affect the results in a
way reminiscent of the one observed for the no angiogen-
esis case in Fig. 13. In Fig. 14, where 0 ≤ β ≤ 0.1, i.e. energy
is acquired mainly through combustion, tumors grow only
if vasculature regression evolves sufficiently slower than
angiogenesis. In Fig. 15 (0.1 ≤ β ≤ 0.2), tumors survive and
grow in many more cases, and in general they reach larger
end populations of viable cells. In Fig. 16 (0.2 ≤ β ≤ 0.3), tu-
mors survive in even more cases, however, end popula-
tions are lower than in Fig. 15. In terms of survival
probabilities, tumors in Fig. 17 (0.3 ≤ β ≤ 0.4) tumors are
slightly better than in Fig. 16, achieve, nevertheless, lower
end populations. In Fig. 18 (0.4 ≤ β ≤ 0.5) tumors survive
almost like in Fig. 17. Again, compared to Fig. 17, survival
probabilities and end populations are lower.
A general observation is that, for the same limits of β
and the same energy requirements λ, maximum rates of
vasculature expansion and regression had monotonic
effects on survival probabilities and viable end popula-
tions. Assuming other parameters equal, a higher max-
imum rate of vasculature expansion generally implies
higher survival probability and viable end population. Re-
spectively, a higher maximum rate of vasculature
regression generally has the opposite effects. There are a
few exceptions in these rules; they are marked by arrows
at the left of each image and we will explain them below.
For all of the aforementioned exceptions, the expected
number of live cancer cells was calculated for each day.
These quantities were plotted in pairs for each case
monotonicity did not hold; three such examples are
shown in Figs. 19, 20, and 21. These Figures depict the
pattern observed for all these cases. The expected behav-
ior of tumor cells growing in more favorable conditions
(blue curves) is to grow faster and larger than their
respective counterparts (red curves) for most of the ob-
served time period. However, they reach a maximum
and start to regress sooner than tumor cells growing in
less favorable conditions. Apparently though, on the
90th day, the sum of viable and necrotic tumor cells is
larger for tumors growing in more favorable conditions.
The effects of λ (i.e. the parameter quantifying the
energy requirements of cancer cells compared to host
cells) are much more complicated. Using the abbrevi-
ations Vasculature Regression minimum Halftime
Fig. 19 Timely evolution of live cancer cells for different vasculature regression and expansion rates. VRmHt: Vasculature Regression minimum
Halftime, VEmDt: Vasculature Expansion minimum Doubling time, d: days
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(VRmHt) and Vasculature Expansion minimum Doub-
ling time (VEmDt) defined for Figs. 19, 20 and 21, we
observe the following. For 0 ≤ β ≤ 0.1, VRmHt = 5 days,
VEmDt = 1 day, λ has an increasing effect on the vi-
able end population. Apparently, in this case, high en-
ergy requirements induce hypoxia and hypoglycemia
much more frequently, thereby triggering vessel ex-
pansion more often. Additionally, tumor-induced
angiogenesis is much faster than tumor-induced vas-
culature regression; this results in higher final popula-
tions of viable cancer cells. The observation that, if
angiogenesis occurs sufficiently faster than vascular
regression, higher energy requirements act increas-
ingly on the viable end population holds in general
for 0 ≤ β ≤ 0.3, see Figs. 14, 15, and 16 . It is much
less pronounced for 0.4 ≤ β ≤ 0.5 (Fig. 18), and does
not hold for 0.3 ≤ β ≤ 0.4 (Fig. 17). As a counterexam-
ple, note that for 0.2 ≤ β ≤ 0.3, VRmHt = 5 days,
VEmDt = 3 days, λ has a decreasing effect on the vi-
able end population.
From the analysis performed so far, no general pattern
providing a quantitative and concise interpretation of
these observations was found. Evidently, the dependen-
cies of the end population of viable cells on the parame-
ters under consideration are quite complex, and display
a rich structure of local maxima and minima. A more
detailed study of these dependencies would require more
simulations for each set of parameter values and add-
itional consideration of standard deviations; we leave this
for future work.
Appendix
IX.i The random perturbation of matrices To and Tgl de-
scribed in part III of the methods section is imple-
mented as follows. There are two parameters involved
– κ, that is, the number of time steps every which the
perturbation is applied to the matrices To and Tgl
calculated by algorithm 2.
– μ, which is a number ranging from 0 to 9.
Every κ time steps, the respective columns of matrices
To and Tgl are perturbed in the following way. Each non-
zero probability of the column to be perturbed is multi-
plied by a uniformly distributed random number ranging
from 1 to 1 + μ. There are 27 nonzero probabilities in
each column, hence, we use 27 such random numbers.
We then normalize these 27 products to sum to 1. Note
that every time we apply this process on a column, the
resulting ratio of any two of the column’s 27 probabil-
ities could be anywhere between 1/(1 + μ) smaller and
Fig. 20 Timely evolution of live cancer cells for different vasculature regression and expansion rates. VRmHt: Vasculature Regression minimum
Halftime, VEmDt: Vasculature Expansion minimum Doubling time, d: days
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1 + μ larger than its original value. Thus, their relative
order of magnitude is preserved.
Sample simulations were performed with time step
Δτ = 10 s, κ = 30, 60 (i.e. perturbations applied every 5
or 10 min) and μ = 1, 4, 9. The resulting cell populations
did not vary significantly. In fact, they displayed an al-
most exact agreement on the numbers corresponding to
their greatest order of magnitude and slight variations
on the number corresponding to their second greatest
order of magnitude. For the simulations described in
section VIII, the values κ = 30 and μ = 1 were used.
IX.ii In this last part, we provide some suggestions on
how the cellular diffusion module (section IV) may be re-
adjusted, in order to consider slightly different sets of
starting assumptions. We do this by discussing four
specific examples, and show that each of them can be im-
plemented using the sparse matrix, vector algebraic frame-
work we propose. The resulting algorithmic modules were
not used for a comprehensive analysis like the one pre-
sented in the main text. In this paper, they serve mainly as
ideas on how to further elaborate on the specific module.
a) For the simulations in the main textMmax was treated
as a constant, and was set 2% larger than M for all
voxels. A more general assumption would be to
assume that for each voxel A the corresponding
number Mmax(A) is a random number ranging close
to M, that also changes with time; The corresponding
implementation is straightforward: each time before
applying Algorithm 2, generate this vector of random
numbers; Then simply apply Algorithm 2, by first
substituting Mmax with this vector.
b) Additionally to the assumptions (i)-(v) in section IV
consider the following:
(vi) Live cancer cells do not invade voxels whose total
necrotic (cancer+normal) cell population is aboveM.
This is an additional scenario that can be quite
easily implemented in the sparse matrix framework
we propose; each time before applying Algorithm 2
find all (new) voxels whose total necrotic
population is above M. For each one of these
voxels, do the following:
– Find the row of the matrix Tc corresponding to the
voxel.
– Find the row’s nonzero elements;
– Set all row elements to zero;
– Normalize the columns of Tc corresponding to the
nonzero elements of the row;
Subsequently, apply Algorithm 2 by using the resulting
form of the matrix Tc
Fig. 21 Timely evolution of live cancer cells for different vasculature regression and expansion rates. VRmHt: Vasculature Regression minimum
Halftime, VEmDt: Vasculature Expansion minimum Doubling time, d: days
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c) Alternatively, instead of the previous additional
assumption, consider the following:
(vi) Live cancer cells invading voxels whose total nec-
rotic (cancer+normal) cell population is above M turn
immediately to necrotic.
The implementation of the corresponding algorithm is a
slight variation of Algorithm 2. We remind that for a vec-
tor x and a number μ, the vector (x ≥ μ) is the binary vec-
tor with elements set to 1 if the corresponding element of
x is ≥μ and 0 otherwise. For vectors x, y, x. ∗ y denotes
their elementwise product. The resulting algorithm is:
s0 ¼ Mmax−nct−nnt
s1 ¼ s0≥0ð Þ:s0
s2 ¼ wt > Mmax
 
:s1
 þ wt ≤Mmax :lt 
ltþΔτ ¼ s2 þ nct þ nntð Þ < Mð Þ: Tc lt−s2ð Þð Þ
nctþΔτ ¼ nct þ nct þ nntð Þ≥Mð Þ: Tc lt−s2ð Þð Þ
Note that in the last two lines, invading cells are added
to the live cancer cells of the invaded voxel if its total
necrotic population is below M. If its total necrotic
population is above M, invading cells are added to the
necrotic cancer cells of the voxel.
d) Last, we informally discuss some ideas on how to
introduce some at least crude, phenomenological
notion of chemotaxis in this module. Chemotaxis
refers to the phenomenon where cells tend to move
towards higher concentrations of specific molecules,
say, for example, oxygen. We remind that each
column of the matrix Tc corresponds to a voxel A.
Each nonzero element of the column corresponds
to a specific neighbor of A. In fact, each nonzero
element is the fraction of live cancer cells in A that
are in excess of Mmax that will invade the respective
neighbor. How can we quantify the tendency of
cells to move towards higher concentrations of
oxygen in this framework? The simplest, although
admittedly crude way is the following. Each time
before executing Algorithm 2, for each voxel that
has been reached by the tumor or is adjacent to it,
multiply elementwise the respective column with
the current vector of oxygen quantities ot. Then
normalize its resulting nonzero elements (which
remain in the same place) to sum to one. This
process rescales the probability of invading each
neighbor according to its respective oxygen content;
We stress that this is merely a rough idea, which
however, we wanted to share. The quantitative
details and overall soundness of this idea remain to
be furtherly analyzed and improved.
Abbreviations
DTI: Diffusion Tensor Imaging; PET: Positron Emission Tomography;
VEmDt: Vasculature Expansion minimum Doubling time; VRmHt: Vasculature
Regression minimum Halftime
Acknowledgements
Fruitful discussions with Christos Kyroudis, Eleftherios Ouzounoglou, Norbert
Graf and Stefaan Van Gool are dully acknowledged.
Authors’ contributions
MA conceived the ideas, developed the respective mathematical arguments
and algorithms and wrote the first draft of the manuscript. DD, GS, NU
provided feedback, reviewed and corrected the manuscript. MA, DD, GS, NU
have read and approved the final manuscript.
Funding
This work was funded in part by the CHIC project (grant agreement No
600841). The funding body did not play any role in the design of the study,
the collection, analysis, and interpretation of data, and in writing the
manuscript.
Availability of data and materials
Data sharing is not applicable to this article as no datasets were generated
or analysed during the current study. All parameter values required to
reproduce the presented simulations are included in this published article.
Ethics approval and consent to participate
Not applicable
Consent for publication
Not applicable
Competing interests
The authors declare that they have no competing interests of any kind.
Received: 23 April 2019 Accepted: 16 July 2019
References
1. Alberts B, Johnson A, Lewis J, Raff M, Roberts K, Walter P. Molecular Biology
of the Cell. 5th ed. New York: Garland Science, Taylor & Francis Group; 2007.
2. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell.
2011;144(5):646–74.
3. Michor F, Iwasa Y, Nowak MA. Dynamics of cancer progression. Nat Rev
Cancer. 2004;4(3):197–205.
4. Vaupel P, Kallinowski F, Okunieff P. Blood flow, oxygen and nutrient supply,
and metabolic microenvironment of human tumors: a review. Cancer Res.
1989;49(23):6449–65.
5. Brown JM, Wilson WR. Exploiting tumour hypoxia in cancer treatment. Nat
Rev Cancer. 2004;4(6):437–47.
6. Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature.
2000;407(6801):249–57.
7. Jain RK, di Tomaso E, Duda DG, Loeffler JS, Sorensen AG, Batchelor TT.
Angiogenesis in brain tumours. Nat Rev Neurosci. 2007;8(8):610–22.
8. Anderson AR, Chaplain MA. Continuous and discrete mathematical models
of tumor-induced angiogenesis. Bull Math Biol. 1998;60(5):857–99.
9. Hirst DG, Denekamp J. Tumour cell proliferation in relation to the
vasculature. Cell Tissue Kinet. 1979;12(1):31–42.
10. Sutherland RM. Cell and environment interactions in tumor microregions:
the multicell spheroid model. Science. 1988;240(4849):177–84.
11. Tannock I. F The relation between cell proliferation and the vascular system
in a transplanted mouse mammary tumour. Br J Cancer. 1968;22(2):258–73.
12. Casciari JJ, Sotirchos SV, Sutherland RM. Glucose diffusivity in multicellular
tumor spheroids. Cancer Res. 1988;48(14):3905–9.
13. Freyer JP, Sutherland RM. Proliferative and clonogenic heterogeneity of cells
from EMT6/Ro multicellular spheroids induced by the glucose and oxygen
supply. Cancer Res. 1986;46(7):3513–20.
14. Schaller G, Meyer-Hermann M. Multicellular tumor spheroid in an off-lattice
Voronoi-Delaunay cell model. Phys Rev E Stat Nonlin Soft Matter Phys. 2005;
71(5 Pt 1):051910.
Antonopoulos et al. BMC Bioinformatics          (2019) 20:442 Page 34 of 36
15. Vavourakis V, Wijeratne PA, Shipley R, Loizidou M, Stylianopoulos T, Hawkes
DJ. A Validated Multiscale In-Silico Model for Mechano-sensitive Tumour
Angiogenesis and Growth. PLoS Comput Biol. 2017;13(1):e1005259.
Published 2017 Jan 26. https://doi.org/10.1371/journal.pcbi.1005259.
16. López AG, Seoane JM, Sanjuán MA. A validated mathematical model of
tumor growth including tumor-host interaction, cell-mediated immune
response and chemotherapy. Bull Math Biol. 2014;76(11):2884–906. https://
doi.org/10.1007/s11538-014-0037-5 Epub 2014 Oct 28.
17. Collis J, Connor AJ, Paczkowski M, Kannan P, Pitt-Francis J, Byrne HM,
Hubbard ME. Bayesian Calibration, Validation and Uncertainty Quantification
for Predictive Modelling of Tumour Growth: A Tutorial. Bull Math Biol. 2017;
79(4):939–74. https://doi.org/10.1007/s11538-017-0258-5 Epub 2017 Mar 13.
18. Portz T, Kuang Y, Nagy JD. A clinical data validated mathematical model of
prostate cancer growth under intermittent androgen suppression therapy.
AIP Advances. 2012;2:011002. https://doi.org/10.1063/1.3697848.
19. Wodarz D, Komarova NL. Dynamics of Cancer: Mathematical Foundations of
Oncology. 1st ed. River Edge: World Scientific Publishing Co., Inc.; 2014.
20. Komarova NL, Burger JA, Wodarz D. Evolution of ibrutinib resistance in chronic
lymphocytic leukemia (CLL). Proc Natl Acad Sci USA. 2014;111(38):13906–11.
21. Rodriguez-Brenes IA, Wodarz D. Preventing clonal evolutionary processes in
cancer: Insights from mathematical models. Proc Natl Acad Sci USA. 2015;
112(29):8843–50.
22. Beerenwinkel N, Schwarz RF, Gerstung M, Markowetz F. Cancer Evolution:
Mathematical Models and Computational Inference. Syst Biol. 2015;64(1):e1–e25.
23. De Pillis LG, Radunskaya AE, Wiseman CL. A validated mathematical model
of cell-mediated immune response to tumor growth. Cancer Res. 2005;
65(17):7950–8.
24. Leon K, Garcia K, Carneiro J, Lage A. How regulatory CD25(+)CD4(+) T cells
impinge on tumor immunobiology? On the existence of two alternative
dynamical classes of tumors. J Theor Biol. 2007;247(1):122–37.
25. Robertson-Tessi M, El-Kareh A, Goriely A. A mathematical model of tumor-
immune interactions. J Theor Biol. 2012;294:56–73.
26. De Pillis LG, Radunskaya A. A Mathematical Tumor Model with Immune
Resistance and Drug Therapy: An Optimal Control Approach. J Theor Med.
2001;3(2):79–100.
27. Castorina P, Carcò D, Guiot C, Deisboeck TS. Tumor growth instability and
its implications for chemotherapy. Cancer Res. 2009;69(21):8507–15.
28. Stura I, Venturino E, Guiot C. A two-clones tumor model: Spontaneous
growth and response to treatment. Math Biosci. 2016;271:19–28.
29. Forouzannia F, Enderling H, Kohandel M. Mathematical Modeling of the
Effects of Tumor Heterogeneity on the Efficiency of Radiation Treatment
Schedule. Bull Math Biol. 2018;80(2):283–93.
30. Patel AA, Gawlinski ET, Lemieux SK, Gatenby RA. A cellular automaton
model of early tumor growth and invasion. J Theor Biol. 2001;213(3):315–31.
31. Alarcón T, Byrne HM, Maini PK. A cellular automaton model for tumour
growth in inhomogeneous environment. J Theor Biol. 2003;225(2):257–74.
32. Alarcón T, Byrne HM, Maini PK. A Multiple Scale Model for Tumor Growth.
Multiscale Model Simul. 2005;2:440–75.
33. Anderson AR. A hybrid mathematical model of solid tumour invasion: the
importance of cell adhesion. Math Med Biol. 2005;22(2):163–86.
34. Anderson AR, Weaver AM, Cummings PT, Quaranta V. Tumor morphology
and phenotypic evolution driven by selective pressure from the
microenvironment. Cell. 2006;127(5):905–15.
35. Wang Z, Zhang L, Sagotsky J, Deisboeck TS. Simulating non-small cell lung
cancer with a multiscale agent-based model. Theor Biol Med Model. 2007;4:50.
36. Gerlee P, Anderson AR. An evolutionary hybrid cellular automaton model of
solid tumour growth. J Theor Biol. 2007;246(4):583–603.
37. Gerlee P, Anderson AR. A hybrid cellular automaton model of clonal
evolution in cancer: the emergence of the glycolytic phenotype. J Theor
Biol. 2008;250(4):705–22.
38. Wang Z, Birch CM, Deisboeck TS. Cross-scale sensitivity analysis of a non-
small cell lung cancer model: linking molecular signaling properties to
cellular behavior. Biosystems. 2008;92(3):249–58.
39. Vital-Lopez FG, Armaou A, Hutnik M, Maranas CD. Modeling the effect of
chemotaxis on glioblastoma tumor progression. AIChE J. 2011;57:778–92.
40. Perfahl H, Byrne HM, Chen T, et al. Multiscale Modelling of Vascular Tumour
Growth in 3D: The Roles of Domain Size and Boundary Conditions. Secomb
TW, ed. PLoS One. 2011;6(4):e14790.
41. Li F, Tan H, Singh J, Yang J, Xia X, Bao J, Ma J, Zhan M, Wong TCS. A 3D
multiscale model of cancer stem cell in tumor development. BMC Syst Biol.
2013;7(Suppl 2):S12.
42. Haridas P, Browning AP, McGovern JA, Sean McElwain DL, Simpson MJ.
Three-dimensional experiments and individual based simulations show that
cell proliferation drives melanoma nest formation in human skin tissue. BMC
Syst Biol. 2018;12:34.
43. Kansal AR, Torquato S, Harsh GR IV, Chiocca EA, Deisboeck TS. Cellular automaton
of idealized brain tumor growth dynamics. Biosyst. 2000;55(1–3):119–27.
44. Macklin P, Edgerton ME, Thompson AM, Cristini V. Patient-calibrated agent-based
modelling of ductal carcinoma in situ (DCIS): from microscopic measurements to
macroscopic predictions of clinical progression. J Theor Biol. 2012;301:122–40.
45. Kempf H, Bleicher M, Meyer-Hermann M. Spatio-Temporal Dynamics of
Hypoxia during Radiotherapy. PLoS One. 2015;10(8):e0133357.
46. Jiang Y, Pjesivac-Grbovic J, Cantrell C, Freyer JP. A Multiscale Model for
Avascular Tumor Growth. Biophys J. 2005;89(6):3884–94.
47. Rubenstein BM, Kaufman LJ. The role of extracellular matrix in glioma
invasion: a cellular Potts model approach. Biophys J. 2008;95(12):5661–80.
48. Shirinifard A, Gens JS, Zaitlen BL, Popławski NJ, Swat M, Glazier JA. 3D multi-cell
simulation of tumor growth and angiogenesis. PLoS One. 2009;4(10):e7190.
49. Szabó A, Merks RM. Cellular potts modeling of tumor growth, tumor
invasion, and tumor evolution. Front Oncol. 2013;3:87.
50. Jeanquartier F, Jean-Quartier C, Cemernek D, Holzinger A. In silico modeling
for tumor growth visualization. BMC Syst Biol. 2016;10(1):59.
51. Ward JP, King JR. Mathematical modelling of avascular-tumour growth. IMA
J Math Appl Med Biol. 1997;14(1):39–69.
52. Venkatasubramanian R, Henson MA, Forbes NS. Incorporating energy
metabolism into a growth model of multicellular tumor spheroids. J Theor
Biol. 2006;242(2):440–53.
53. Schaller G, Meyer-Hermann M. Continuum versus discrete model: a
comparison for multicellular tumour spheroids. Philos Trans A Math Phys
Eng Sci. 2006;364(1843):1443–64.
54. Stein AM, Demuth T, Mobley D, Berens M, Sander LM. A Mathematical
Model of Glioblastoma Tumor Spheroid Invasion in a Three-Dimensional In
Vitro Experiment. Biophys J. 2007;92(1):356–65.
55. Swanson KR, Bridge C, Murray JD, Alvord EC Jr. Virtual and real brain tumors:
using mathematical modeling to quantify glioma growth and invasion. J
Neurol Sci. 2003;216(1):1–10.
56. Jbabdi S, Mandonnet E, Duffau H, Capelle L, Swanson KR, Pélégrini-Issac M,
Guillevin R, Benali H. Simulation of anisotropic growth of low-grade gliomas
using diffusion tensor imaging. Magn Reson Med. 2005;54(3):616–24.
57. Clatz O, Sermesant M, Bondiau PY, Delingette H, Warfield SK, Malandain G,
Ayache N. Realistic simulation of the 3-D growth of brain tumors in MR
images coupling diffusion with biomechanical deformation. IEEE Trans Med
Imaging. 2005;24(10):1334–46.
58. Rockne R, Rockhill JK, Mrugala M, Spence AM, Kalet I, Hendrickson K, Lai A,
Cloughesy T, Alvord EC Jr, Swanson KR. Predicting efficacy of radiotherapy
in individual glioblastoma patients in vivo: a mathematical modeling
approach. Phys Med Biol. 2010;55(12):3271–85.
59. Painter KJ, Hillen T. Mathematical modelling of glioma growth: the use of
Diffusion Tensor Imaging (DTI) data to predict the anisotropic pathways of
cancer invasion. J Theor Biol. 2013;323:25–39.
60. Patel V, Hathout L. Image-driven modeling of the proliferation and necrosis
of glioblastoma multiforme. Theor Biol Med Model. 2017;14(1):10.
61. Swan A, Hillen T, Bowman JC, Murtha AD. A Patient-Specific Anisotropic
Diffusion Model for Brain Tumour Spread. Bull Math Biol. 2018;80(5):1259–91.
62. Cristini V, Lowengrub J, Nie Q. Nonlinear simulation of tumor growth. J
Math Biol. 2003;46(3):191–224.
63. Li X, Cristini V, Nie Q, Lowengrub JS. Nonlinear three-dimensional simulation
of solid tumor growth. Discrete Control Dyn Syst. 2007;7(3):581–604.
64. Zheng X, Wise SM, Cristini V. Nonlinear simulation of tumor necrosis, neo-
vascularization and tissue invasion via an adaptive finite-element/level-set
method. Bull Math Biol. 2005;67(2):211–59.
65. Hogea CS, Murray BT, Sethian JA. Simulating complex tumor dynamics from
avascular to vascular growth using a general level-set method. J Math Biol.
2006;53(1):86–134.
66. Macklin P, Lowengrub J. Nonlinear simulation of the effect of
microenvironment on tumor growth. J Theor Biol. 2007;245(4):677–704.
67. Macklin P, Lowengrub JS. A New Ghost Cell/Level Set Method for Moving
Boundary Problems: Application to Tumor Growth. J Sci Commun. 2008;
35(2–3):266–99.
68. Macklin P, McDougall S, Anderson AR, Chaplain MA, Cristini V, Lowengrub J.
Multiscale modelling and nonlinear simulation of vascular tumour growth. J
Math Biol. 2009;58(4–5):765–98.
Antonopoulos et al. BMC Bioinformatics          (2019) 20:442 Page 35 of 36
69. Wise SM, Lowengrub JS, Frieboes HB, Cristini V. Three-dimensional
multispecies nonlinear tumor growth--I Model and numerical method. J
Theor Biol. 2008;253(3):524–43.
70. Cristini V, Li X, Lowengrub JS, Wise SM. Nonlinear simulations of solid tumor growth
using a mixture model: invasion and branching. J Math Biol. 2009;58(4–5):723–63.
71. Frieboes HB, Jin F, Chuang YL, Wise SM, Lowengrub JS, Cristini V. Three-
dimensional multispecies nonlinear tumor growth-II: Tumor invasion and
angiogenesis. J Theor Biol. 2010;264(4):1254–78.
72. Sciumè G, Shelton S, Gray W, Miller C, Hussain F, Ferrari M, Decuzzi P,
Schrefler B. A multiphase model for three-dimensional tumor growth. New J
Phys. 2013;15:015005.
73. Chen Y, Wise SM, Shenoy VB, Lowengrub JS. A stable scheme for a
nonlinear, multiphase tumor growth model with an elastic membrane. Int J
Numer Method Biomed Eng. 2014 Jul;30(7):726–54.
74. Dionysiou DD, Stamatakos GS, Uzunoglu NK, Nikita KS, Marioli A. A four-
dimensional simulation model of tumour response to radiotherapy in vivo:
parametric validation considering radiosensitivity, genetic profile and
fractionation. J Theor Biol. 2004;230(1):1–20.
75. Kolokotroni EA, Dionysiou DD, Uzunoglu NK, Stamatakos GS. Studying the
growth kinetics of untreated clinical tumors by using an advanced discrete
simulation model. Math Comput Model. 2011;54:1989–2006.
76. Kolokotroni E, Dionysiou D, Veith C, Kim YJ, Sabczynski J, Franz A, Grgic A,
Palm J, Bohle RM, Stamatakos G. In Silico Oncology: Quantification of the In
Vivo Antitumor Efficacy of Cisplatin-Based Doublet Therapy in Non-Small
Cell Lung Cancer (NSCLC) through a Multiscale Mechanistic Model. PLoS
Comput Biol. 2016;12(9):e1005093.
77. Kim Y, Stolarska MA, Othmer HG. A Hybrid Model for Tumor Spheroid
Growth in vitro I: Theoretical Development and Early Results. Math Models
Methods Appl Sci. 2007;17:1773–98.
78. Kim Y, Othmer H. Hybrid models of cell and tissue dynamics in tumor
growth. Math Biosci Eng. 2015;12(6):1141–56.
79. Deisboeck TS, Stamatakos GS. Multiscale Cancer Modeling. Boca Raton:
Taylor & Francis; 2011.
80. Antonopoulos M, Stamatakos G. In Silico Neuro-Oncology: Brownian
Motion-Based Mathematical Treatment as a Potential Platform for Modeling
the Infiltration of Glioma Cells into Normal Brain Tissue. Cancer Inform.
2015;14(Suppl 4):33.
81. Grigoriu M. Stochastic Calculus: Applications in Science and Engineering
(Chap. 7). Birkhäuser: Switzerland; 2003.
82. Stamatakos G, Giatili S. A Numerical Handling of the Boundary Conditions
Imposed by the Skull on an Inhomogeneous Diffusion Reaction Model of
Glioblastoma Invasion Into the Brain: Clinical Validation Aspects. Cancer
Informat. 2017;16(16):1–16.
83. Helmlinger G, Yuan F, Dellian M, Jain RK. Interstitial pH and pO2 gradients in
solid tumors in vivo: high-resolution measurements reveal a lack of
correlation. Nat Med. 1997;3(2):177–82.
84. Freyer JP, Sutherland RM. Regulation of growth saturation and development
of necrosis in EMT6/Ro multicellular spheroids by the glucose and oxygen
supply. Cancer Res. 1986;46(7):3504–12.
85. Freyer JP, Tustanoff E, Franko AJ, Sutherland RM. In situ oxygen
consumption rates of cells in V-79 multicellular spheroids during growth. J
Cell Physiol. 1984;118(1):53–61.
86. Casciari JJ, Sotirchos SV, Sutherland RM. Variations in tumor cell growth
rates and metabolism with oxygen concentration, glucose concentration,
and extracellular pH. J Cell Physiol. 1992;151(2):386–94.
87. Kunz-Schughart LA, Doetsch J, Mueller-Klieser W, Groebe K. Proliferative
activity and tumorigenic conversion: Impact on cellular metabolism in 3-d
culture. Am J Physio Cell Physiol. 2000;278:765–80.
88. Wehrle JP, Ng CE, McGovern KA, Aiken NR, Shungu DC, Chance EM,
Glickson JD. Metabolism of alternative substrates and the bioenergetic
status of EMT6 tumor cell spheroids. NMR in Biomed. 2000;13:349–460.
89. Freyer JP, Sutherland RM. A reduction in the in situ rates of oxygen and
glucose consumption of cells in EMT6/Ro spheroids during growth. J Cell
Physiol. 1985;124(3):516–24.
90. Gatenby RA, Gillies RJ. Why do cancers have high aerobic glycolysis? Nat
Rev Cancer. 2004;4(11):891–9.
91. Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg
effect: the metabolic requirements of cell proliferation. Science. 2009;
324(5930):1029–33.
92. Despopoulos A, Silbernagl S. Color Atlas of Physiology (6th edition).
Stuttgart: Thieme; 2003.
93. Wagner BA, Venkataraman S, Buettner GR. The rate of oxygen utilization by
cells. Free Radic Biol Med. 2011;51(3):700–12.
94. Holash J, Maisonpierre PC, Compton D, Boland P, Alexander CR, Zagzag D,
Yancopoulos GD, Wiegand SJ. Vessel cooption, regression, and growth in
tumors mediated by angiopoietins and VEGF. Science. 1999;284(5422):1994–8.
95. Holash J, Wiegand SJ, Yancopoulos GD. New model of tumor angiogenesis:
dynamic balance between vessel regression and growth mediated by
angiopoietins and VEGF. Oncogene. 1999;18(38):5356–62.
96. Lee DS, Rieger H, Bartha K. Flow correlated percolation during vascular
remodeling in growing tumors. Phys Rev Lett. 2006;96(5):058104.
97. Bartha K, Rieger H. Vascular network remodeling via vessel cooption,
regression and growth in tumors. J Theor Biol. 2006;241(4):903–18.
98. Ganong W. Review of Medical Physiology. 19th ed. New York: Appleton &
Lange; 1999.
99. Murray JD. Mathematical Biology II: Spatial Models and Biomedical
Applications (3rd edition). New York: Springer-Verlag; 2011.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Antonopoulos et al. BMC Bioinformatics          (2019) 20:442 Page 36 of 36
